{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:27:33Z","timestamp":1787927253886,"version":"build-2784847793"},"reference-count":290,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100016888","name":"Bayer Foundation","doi-asserted-by":"publisher","award":["PHD-MEDHA-2023-10970"],"award-info":[{"award-number":["PHD-MEDHA-2023-10970"]}],"id":[{"id":"10.13039\/100016888","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Directorate of Technical Education - Chief Minister Research Grant","award":["CMRG\/3005\/H3\/2024\/011"],"award-info":[{"award-number":["CMRG\/3005\/H3\/2024\/011"]}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EEQ\/2021\/000203"],"award-info":[{"award-number":["EEQ\/2021\/000203"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10787-026-02346-8","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:41:11Z","timestamp":1784619671000},"page":"5169-5210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance"],"prefix":"10.1007","volume":"34","author":[{"given":"Benedict Mathews","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowtham","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunachalam","family":"Karuppasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5874-8949","authenticated-orcid":false,"given":"Parimelazhagan","family":"Thangaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"19","key":"2346_CR1","doi-asserted-by":"publisher","first-page":"16620","DOI":"10.1021\/acsomega.2c07254","volume":"8","author":"AA Abd-Elghany","year":"2023","unstructured":"Abd-Elghany AA, Mohamad EA (2023) Chitosan-coated niosomes loaded with ellagic acid present antiaging activity in a skin cell line. ACS Omega 8(19):16620\u201316629. https:\/\/doi.org\/10.1021\/acsomega.2c07254","journal-title":"ACS Omega"},{"issue":"6","key":"2346_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.69613\/0dp7yg94","volume":"3","author":"SF Ahmed","year":"2025","unstructured":"Ahmed SF, Munaf SS (2025) A review on molecular pathways of procyanidin C1 in modulating inflammation, oxidative stress, and apoptosis in senescent cells. J Pharma Insights Res 3(6):43\u201352. https:\/\/doi.org\/10.69613\/0dp7yg94","journal-title":"J Pharma Insights Res"},{"issue":"2","key":"2346_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/antiox14020199","volume":"14","author":"Y Aleksandrova","year":"2025","unstructured":"Aleksandrova Y, \u041d\u0435\u0433\u0430\u043d\u043e\u0432\u0430 \u041c\u0415 (2025) Antioxidant senotherapy by natural compounds: a beneficial partner in cancer treatment. Antioxidants 14(2):199\u2013199. https:\/\/doi.org\/10.3390\/antiox14020199","journal-title":"Antioxidants"},{"issue":"18","key":"2346_CR4","doi-asserted-by":"publisher","first-page":"10692","DOI":"10.3390\/ijms231810692","volume":"23","author":"DL Almeida-Nunes","year":"2022","unstructured":"Almeida-Nunes DL, Mendes-Frias A, Silvestre R, Dinis\u2010Oliveira RJ, Ricardo S (2022) Immune tumor microenvironment in ovarian cancer ascites. Int J Mol Sci 23(18):10692\u201310692. https:\/\/doi.org\/10.3390\/ijms231810692","journal-title":"Int J Mol Sci"},{"key":"2346_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00743","author":"H Alsamri","year":"2019","unstructured":"Alsamri H, Hasasna HE, Dhaheri YA, Eid AH, Attoub S, Iratni R (2019) Carnosol, a natural polyphenol, inhibits migration, metastasis, and tumor growth of breast cancer via a ROS-dependent proteasome degradation of STAT3. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.00743","journal-title":"Front Oncol"},{"issue":"50","key":"2346_CR6","doi-asserted-by":"publisher","first-page":"35251","DOI":"10.1039\/d3ra07391b","volume":"13","author":"DM Alshangiti","year":"2023","unstructured":"Alshangiti DM, El-damhougy TK, Zaher AA, Madani M, Ghobashy MM (2023) Revolutionizing biomedicine: advancements, applications, and prospects of nanocomposite macromolecular carbohydrate-based hydrogel biomaterials: a review. RSC Adv 13(50):35251\u201335291. https:\/\/doi.org\/10.1039\/d3ra07391b","journal-title":"RSC Adv"},{"key":"2346_CR7","doi-asserted-by":"publisher","DOI":"10.64252\/za0cxz36","author":"S Amudha","year":"2025","unstructured":"Amudha S (2025) Nanoparticle-embedded hydrogels for phytoconstituents delivery: a smart approach to drug delivery systems. Int J Environ Sci. https:\/\/doi.org\/10.64252\/za0cxz36","journal-title":"Int J Environ Sci"},{"issue":"1","key":"2346_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2013.02.032","volume":"334","author":"F Aqil","year":"2013","unstructured":"Aqil F, Munagala R, Jeyabalan J, Vadhanam MV (2013) Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett 334(1):133\u2013141. https:\/\/doi.org\/10.1016\/j.canlet.2013.02.032","journal-title":"Cancer Lett"},{"key":"2346_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.975320","author":"M Atteeq","year":"2022","unstructured":"Atteeq M (2022) Evaluating anticancer properties of Withaferin A\u2014a potent phytochemical. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.975320","journal-title":"Frontiers Pharmacology 13 Front Media"},{"key":"2346_CR10","doi-asserted-by":"publisher","unstructured":"Barkovskaya A, Brauning A, Chamoli M, Rane A, Andersen JK, Sharma A (2025a) Mitigating proinflammatory SASP and DAMP with urolithin a: a novel senomorphic strategy. In bioRxiv (Cold Spring Harbor Laboratory). Cold Spring Harbor Laboratory. https:\/\/doi.org\/10.1101\/2025.01.07.631588","DOI":"10.1101\/2025.01.07.631588"},{"key":"2346_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70237","author":"A Barkovskaya","year":"2025","unstructured":"Barkovskaya A, Brauning A, Thambala A, Bhardwaj K, Chamoli M, Rane A, Andersen JK, Sharma A (2025b) Mitigating pro-inflammatory SASP and DAMP with urolithin a: a novel senomorphic strategy. Aging Cell. https:\/\/doi.org\/10.1111\/acel.70237","journal-title":"Aging Cell"},{"issue":"2","key":"2346_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/ijms21020684","volume":"21","author":"Y Bian","year":"2020","unstructured":"Bian Y, Wei J, Zhao C, Li G (2020) Natural polyphenols targeting senescence: a novel prevention and therapy strategy for cancer. Int J Mol Sci 21(2):684\u2013684. https:\/\/doi.org\/10.3390\/ijms21020684","journal-title":"Int J Mol Sci"},{"key":"2346_CR13","doi-asserted-by":"publisher","first-page":"111689","DOI":"10.1016\/j.mad.2022.111689","volume":"206","author":"E Bientinesi","year":"2022","unstructured":"Bientinesi E, Lulli M, Becatti M, Ristori S, Margheri F, Monti D (2022) Doxorubicin-induced senescence in normal fibroblasts promotes in vitro tumour cell growth and invasiveness: the role of quercetin in modulating these processes. Mech Ageing Dev 206:111689\u2013111689. https:\/\/doi.org\/10.1016\/j.mad.2022.111689","journal-title":"Mech Ageing Dev"},{"key":"2346_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00145","author":"O Bilyk","year":"2017","unstructured":"Bilyk O, Coatham M, Jewer M, Postovit L (2017) Epithelial-to-mesenchymal transition in the female reproductive tract: from normal functioning to disease pathology. Front Oncol Front Media. https:\/\/doi.org\/10.3389\/fonc.2017.00145","journal-title":"Frontiers Oncology 7 Front Media"},{"key":"2346_CR15","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1101\/gad.343129.120","volume":"34","author":"J Birch","year":"2020","unstructured":"Birch J, Gil J (2020) Senescence and the SASP: many therapeutic avenues. Genes Dev 34:1565\u20131576. https:\/\/doi.org\/10.1101\/gad.343129.120","journal-title":"Genes Dev"},{"issue":"7","key":"2346_CR16","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3390\/biomedicines10071468","volume":"10","author":"V Borgonetti","year":"2022","unstructured":"Borgonetti V, Galeotti N (2022) Rosmarinic acid reduces microglia senescence: a novel therapeutic approach for the management of neuropathic pain symptoms. Biomedicines 10(7):1468\u20131468. https:\/\/doi.org\/10.3390\/biomedicines10071468","journal-title":"Biomedicines"},{"issue":"12","key":"2346_CR17","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.3390\/nu13124550","volume":"13","author":"JL Boyajian","year":"2021","unstructured":"Boyajian JL, Ghebretatios M, Schaly S, Islam P, Prakash S (2021) Microbiome and human aging: probiotic and prebiotic potentials in longevity, skin health and cellular senescence. Nutrients 13(12):4550\u20134550. https:\/\/doi.org\/10.3390\/nu13124550","journal-title":"Nutrients"},{"issue":"15","key":"2346_CR18","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.7150\/jca.20314","volume":"8","author":"DL Cai","year":"2017","unstructured":"Cai DL, Jin L (2017) Immune cell population in ovarian tumor microenvironment. J Cancer 8(15):2915\u20132923. https:\/\/doi.org\/10.7150\/jca.20314","journal-title":"J Cancer"},{"issue":"7","key":"2346_CR20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41422-020-0314-9","volume":"30","author":"Y Cai","year":"2020","unstructured":"Cai Y, Zhou H, Zhu Y, Sun Q, Ji Y, Xue A, Wang Y, Chen W, Yu X, Wang L, Chen H, Li C, Luo T, Deng H (2020) Elimination of senescent cells by \u03b2-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell Res 30(7):574\u2013589. https:\/\/doi.org\/10.1038\/s41422-020-0314-9","journal-title":"Cell Res"},{"key":"2346_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1291559","author":"X Cai","year":"2024","unstructured":"Cai X, Li Y, Zheng J, Liu L, Jiao Z, Lin J, Jiang S, Lin X, Sun Y (2024) Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2023.1291559","journal-title":"Front Oncol"},{"key":"2346_CR21","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.5c03679","author":"EE \u00c7al\u0131\u015fkan","year":"2025","unstructured":"\u00c7al\u0131\u015fkan EE, Ayd\u0131n Y\u00c7, Ozbek EN, Alcin I, Yetik-Anacak KILINCE, G., Uyanikgil E, \u00d6. \u00c7 (2025) In vitro drug release kinetics and antioxidant activity of metformin-loaded niosomes. ACS Omega. https:\/\/doi.org\/10.1021\/acsomega.5c03679","journal-title":"ACS Omega"},{"issue":"1","key":"2346_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","volume":"75","author":"J Campisi","year":"2012","unstructured":"Campisi J (2012) Aging, cellular senescence, and cancer. Annual Rev Physiol 75(1):685\u2013705. https:\/\/doi.org\/10.1146\/annurev-physiol-030212-183653","journal-title":"Annual Rev Physiol Annual Reviews"},{"key":"2346_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00830-x","author":"H Cao","year":"2021","unstructured":"Cao H, Duan L, Zhang Y, Cao J, Zhang K (2021) Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-021-00830-x","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.freeradbiomed.2015.02.022","volume":"83","author":"AC Carvalho","year":"2015","unstructured":"Carvalho AC, Gomes AC, Pereira-Wilson C, Lima CF (2015) Redox-dependent induction of antioxidant defenses by phenolic diterpenes confers stress tolerance in normal human skin fibroblasts: Insights on replicative senescence. Free Radic Biol Med 83:262\u2013272. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.02.022","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"2346_CR25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.semcancer.2013.08.007","volume":"23","author":"V Catalano","year":"2013","unstructured":"Catalano V, Turdo A, Franco SD, Dieli F, Todaro M, Stassi G (2013) Tumor and its microenvironment: a synergistic interplay. Sem Cancer Biol 23(6):522\u2013532 Elsevier BV. https:\/\/doi.org\/10.1016\/j.semcancer.2013.08.007","journal-title":"Sem Cancer Biol"},{"key":"2346_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0205-z","author":"RD Cervantes-Villagrana","year":"2020","unstructured":"Cervantes-Villagrana RD, Albores\u2010Garc\u00eda D, Cervantes-Villagrana AR, Garc\u00eda-Acevez SJ (2020) Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-020-0205-z","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00712-x","author":"S Chaib","year":"2024","unstructured":"Chaib S, L\u00f3pez-Dom\u00ednguez JA, Lalinde-Guti\u00e9rrez M, Prats N, Mar\u00edn I, Boix O, Garc\u00eda-Garijo A, Meyer K, Mu\u00f1oz MI, Aguilera M, Mateo L, Attolini CS, Llanos S, P\u00e9rez-Ramos S, Escorihuela M, Al\u2010Shahrour F, Cash TP, Tchkonia T, Kirkland JL, Serrano M (2024) The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nat Cancer. https:\/\/doi.org\/10.1038\/s43018-023-00712-x","journal-title":"Nat Cancer"},{"key":"2346_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01865-0","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Narayanan J, Rao DP, Thamaraikani T, Vasanthan M, Viktor P, Natrayan L, Saadh MJ, Amajd A, Abo-Zaid MA, Castillo-Acobo RY, Ismail A, Amin AH, Akhavan\u2010Sigari R (2023) Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-023-01865-0","journal-title":"Mol Cancer"},{"key":"2346_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00752","author":"S Chei","year":"2019","unstructured":"Chei S, Oh H, Song J, Seo Y, Lee K, Lee B-Y (2019) Magnolol suppresses TGF-\u03b2-induced epithelial-to-mesenchymal transition in human colorectal cancer cells. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.00752","journal-title":"Front Oncol"},{"issue":"4","key":"2346_CR30","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.foodchem.2012.11.139","volume":"138","author":"AY Chen","year":"2012","unstructured":"Chen AY, Chen Y (2012) A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem 138(4):2099\u20132107. https:\/\/doi.org\/10.1016\/j.foodchem.2012.11.139","journal-title":"Food Chem"},{"issue":"6","key":"2346_CR32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.mito.2010.08.001","volume":"10","author":"G Chen","year":"2010","unstructured":"Chen G, Wang F, Trachootham D, Huang P (2010) Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion 10(6):614\u2013625 Elsevier BV. https:\/\/doi.org\/10.1016\/j.mito.2010.08.001","journal-title":"Mitochondrion"},{"key":"2346_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06860-4","author":"F Chen","year":"2018","unstructured":"Chen F, Long Q, Fu D, Zhu D, Ma Y, Liu H, Zhang B, Xu Q, Liu-Lastres B, Li Y, Wu S, Chen Y, Qian M, Xu J, Liu S, Cao L, Chin YE, Lam EW-F, Copp\u00e9 J, Sun Y (2018) Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-018-06860-4","journal-title":"Nat Commun"},{"key":"2346_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.597672","author":"S Chen","year":"2020","unstructured":"Chen S, Shen J, Zhao J, Wang J, Shan T, Li J, Xu M, Chen X, Liu Y, Cao G (2020) Magnolol suppresses pancreatic cancer development in vivo and in vitro via negatively regulating TGF-\u03b2\/smad signalling. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.597672","journal-title":"Front Oncol"},{"key":"2346_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.917266","author":"P Chen","year":"2022","unstructured":"Chen P, Guo Z, Chen F, Wu Y, Zhou B (2022) Recent advances and perspectives on the health benefits of urolithin B, A bioactive natural product derived from ellagitannins. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.917266","journal-title":"Frontiers Pharmacology 13 Front Media"},{"issue":"1","key":"2346_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13018-022-03463-0","volume":"18","author":"R Chen","year":"2023","unstructured":"Chen R, Zhang X, Zhu X, Wang C, Xu W (2023a) Myricetin alleviated hydrogen peroxide-induced cellular senescence of nucleus pulposus cell through regulating SERPINE1. J Orthop Surg Res 18(1):143\u2013143. https:\/\/doi.org\/10.1186\/s13018-022-03463-0","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"2346_CR38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"X Chen","year":"2023","unstructured":"Chen X, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, Bao Z, Lu J, Li L (2023b) Evolving cognition of the JAK-STAT signalling pathway: autoimmune disorders and cancer. Signal Transduct Target Therapy 8(1):204\u2013204. https:\/\/doi.org\/10.1038\/s41392-023-01468-7","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR36","doi-asserted-by":"publisher","first-page":"107288","DOI":"10.1016\/j.phrs.2024.107288","volume":"206","author":"X Chen","year":"2024","unstructured":"Chen X, Wei C, Zhao J, Zhou D, Wang Y, Zhang S, Zuo H, Dong J, Zhao Z, Hao M, He X, Bian Y (2024) Carnosic acid: an effective phenolic diterpenoid for prevention and management of cancers via targeting multiple signalling pathways. Pharmacol Res 206:107288\u2013107288. https:\/\/doi.org\/10.1016\/j.phrs.2024.107288","journal-title":"Pharmacol Res"},{"issue":"1","key":"2346_CR37","doi-asserted-by":"publisher","first-page":"2576199","DOI":"10.1080\/10717544.2025.2576199","volume":"33","author":"X Chen","year":"2025","unstructured":"Chen X, Wei Y, Chen X, Zheng L, Zhao Y, You J, Cheng Y, Yang X (2025) Hydrogel-Based intraperitoneal drug delivery platforms for peritoneal metastasis: strategies, advances, and prospects. Drug Delivery 33(1):2576199\u20132576199. https:\/\/doi.org\/10.1080\/10717544.2025.2576199","journal-title":"Drug Delivery"},{"key":"2346_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.963004","author":"X Cheng","year":"2022","unstructured":"Cheng X, Yan H, Pang S, Ya M, Qiu F, Qin P, Zeng C, Lu Y (2022) Liposomes as multifunctional nano-carriers for medicinal natural products. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2022.963004","journal-title":"Frontiers Chemistry 10 Front Media"},{"issue":"10","key":"2346_CR40","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrd.2017.116","volume":"16","author":"BG van Childs","year":"2017","unstructured":"Childs BG, Gluscevic M, Baker DJ, Laberge R-M, Marquess D, Dananberg J, van Deursen JM (2017) Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov 16(10):718\u2013735. https:\/\/doi.org\/10.1038\/nrd.2017.116","journal-title":"Nat Rev Drug Discovery"},{"key":"2346_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13979","author":"AF Chin","year":"2023","unstructured":"Chin AF, Han J, Clement CC, Choi TH, Zhang H, Browne M, Jeon OH, Elisseeff JH (2023) Senolytic treatment reduces oxidative protein stress in an aging male murine model of post-traumatic osteoarthritis. Aging Cell. https:\/\/doi.org\/10.1111\/acel.13979","journal-title":"Aging Cell"},{"issue":"23","key":"2346_CR42","doi-asserted-by":"publisher","first-page":"5930","DOI":"10.3390\/cancers14235930","volume":"14","author":"C Clemente-Gonz\u00e1lez","year":"2022","unstructured":"Clemente-Gonz\u00e1lez C, Carnero A (2022) Role of the hypoxic-secretome in seed and soil metastatic preparation. Cancers 14(23):5930\u20135930. https:\/\/doi.org\/10.3390\/cancers14235930","journal-title":"Cancers"},{"issue":"7","key":"2346_CR43","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.ccell.2025.05.015","volume":"43","author":"M Colucci","year":"2025","unstructured":"Colucci M, Sarill M, Maddalena M, Valdata A, Troiani M, Massarotti M, Bolis M, Bressan S, Kohl A, Robesti D, Saponaro M, Qiu S, Song P, Brina D, Cal\u00ec B, Alimonti A (2025) Senescence in cancer. Cancer Cell 43(7):1204\u20131226. https:\/\/doi.org\/10.1016\/j.ccell.2025.05.015","journal-title":"Cancer Cell"},{"issue":"1","key":"2346_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"J Copp\u00e9","year":"2010","unstructured":"Copp\u00e9 J, Desprez P, Krtolica A, Campisi J (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol Mech Dis 5(1):99\u2013118. https:\/\/doi.org\/10.1146\/annurev-pathol-121808-102144","journal-title":"Annual Rev Pathol Mech Disease"},{"issue":"2","key":"2346_CR45","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1021\/acsnano.9b09213","volume":"14","author":"S Correa","year":"2020","unstructured":"Correa S, Boehnke N, Barberio AE, Deiss-Yehiely E, Shi AC, Oberlton B, Smith SG, Zervantonakis IK, Dreaden EC, Hammond PT (2020) Tuning nanoparticle interactions with ovarian cancer through layer-by-layer modification of surface chemistry. ACS Nano 14(2):2224\u20132237. https:\/\/doi.org\/10.1021\/acsnano.9b09213","journal-title":"ACS Nano"},{"key":"2346_CR46","doi-asserted-by":"publisher","first-page":"102619","DOI":"10.1016\/j.arr.2024.102619","volume":"104","author":"C Costa","year":"2024","unstructured":"Costa C, Pedrosa SS, Kirkland JL, Reis F, Madureira AR (2024) The senotherapeutic potential of phytochemicals for age-related intestinal disease. Ageing Res Rev 104:102619\u2013102619. https:\/\/doi.org\/10.1016\/j.arr.2024.102619","journal-title":"Ageing Res Rev"},{"issue":"13","key":"2346_CR71","doi-asserted-by":"publisher","first-page":"7163","DOI":"10.3390\/ijms25137163","volume":"25","author":"MCX de Godoy","year":"2024","unstructured":"de Godoy MCX, Monteiro GA, de Moraes BH, Macedo JA, Gon\u00e7alves GMS, Gambero A (2024) Addition of polyphenols to drugs: the potential of controlling inflammaging and fibrosis in human senescent lung fibroblasts in vitro. Int J Mol Sci 25(13):7163\u20137163. https:\/\/doi.org\/10.3390\/ijms25137163","journal-title":"Int J Mol Sci"},{"key":"2346_CR227","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.hermed.2017.09.002","volume":"11","author":"K de Vries","year":"2017","unstructured":"de Vries K, Strydom M, Steenkamp V (2017) Bioavailability of resveratrol: Possibilities for enhancement. J Herb Med 11:71\u201377. https:\/\/doi.org\/10.1016\/j.hermed.2017.09.002","journal-title":"J Herb Med"},{"issue":"4","key":"2346_CR47","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1042\/bst20231066","volume":"52","author":"V Dhokia","year":"2024","unstructured":"Dhokia V, Albati A, Smith H, Thomas G, Macip S (2024) A second generation of senotherapies: the development of targeted senolytics, senoblockers and senoreversers for healthy ageing. Biochem Soc Trans 52(4):1661\u20131671. https:\/\/doi.org\/10.1042\/bst20231066","journal-title":"Biochem Soc Trans"},{"key":"2346_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02555-3","author":"A Domen","year":"2022","unstructured":"Domen A, Deben C, Verswyvel J, Flieswasser T, Prenen H, Peeters M, Lardon F, Wouters A (2022) Cellular senescence in cancer: clinical detection and prognostic implications. J Exp Clin Cancer Res. https:\/\/doi.org\/10.1186\/s13046-022-02555-3","journal-title":"J Experimental Clin Cancer Res"},{"issue":"1","key":"2346_CR49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12943-024-02096-7","volume":"23","author":"Z Dong","year":"2024","unstructured":"Dong Z, Luo Y, Yuan Z, Tian Y, Jin T, Feng X (2024) Cellular senescence and SASP in tumor progression and therapeutic opportunities. Mol Cancer 23(1):181\u2013181. https:\/\/doi.org\/10.1186\/s12943-024-02096-7","journal-title":"Mol Cancer"},{"issue":"28","key":"2346_CR50","doi-asserted-by":"publisher","first-page":"20089","DOI":"10.18632\/oncotarget.24015","volume":"9","author":"J Dou","year":"2018","unstructured":"Dou J, Wang Z, Ma L, Peng B, Mao K, Li C, Su M, Zhou C, Peng G (2018) Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence. Oncotarget 9(28):20089\u201320102. https:\/\/doi.org\/10.18632\/oncotarget.24015","journal-title":"Oncotarget"},{"key":"2346_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ctrv.2016.08.007","volume":"50","author":"L Dumas","year":"2016","unstructured":"Dumas L, Ring A, Butler J, Kalsi T, Harari D, Banerjee S (2016) Improving outcomes for older women with gynaecological malignancies. Cancer Treat Rev 50:99\u2013108. https:\/\/doi.org\/10.1016\/j.ctrv.2016.08.007","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"2346_CR52","doi-asserted-by":"publisher","first-page":"236","DOI":"10.7150\/ntno.77564","volume":"7","author":"A Eftekhari","year":"2023","unstructured":"Eftekhari A, Kryschi C, Pamies D, G\u00fcle\u00e7 \u015e, Ahmadian E, Janas D, Davaran S, Khalilov R (2023) Natural and synthetic nanovectors for cancer therapy. Nanotheranostics 7(3):236\u2013257. https:\/\/doi.org\/10.7150\/ntno.77564","journal-title":"Nanotheranostics"},{"key":"2346_CR53","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.actbio.2024.01.002","volume":"176","author":"B Escriche-Navarro","year":"2024","unstructured":"Escriche-Navarro B, Garrido EMN, Sancen\u00f3n F, Garc\u00eda\u2010Fern\u00e1ndez A, Mart\u00ednez\u2010M\u00e1\u00f1ez R (2024) A navitoclax-loaded nanodevice targeting matrix metalloproteinase-3 for the selective elimination of senescent cells. Acta Biomater 176:405\u2013416. https:\/\/doi.org\/10.1016\/j.actbio.2024.01.002","journal-title":"Acta Biomater"},{"issue":"5","key":"2346_CR54","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1039\/c9np00057g","volume":"37","author":"LW Evans","year":"2020","unstructured":"Evans LW, Stratton MS, Ferguson BS (2020) Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease. Nat Prod Rep 37(5):653\u2013676. https:\/\/doi.org\/10.1039\/c9np00057g","journal-title":"Nat Prod Rep"},{"issue":"25","key":"2346_CR55","doi-asserted-by":"publisher","first-page":"22774","DOI":"10.1021\/acsomega.3c01681","volume":"8","author":"SA Fahmy","year":"2023","unstructured":"Fahmy SA, Nasr SM, Ramzy A, Dawood A, Abdelnaser A, Azzazy HME-S (2023) Cytotoxic and antioxidative effects of geranium oil and ascorbic acid coloaded in niosomes against MCF-7 breast cancer cells. ACS Omega 8(25):22774\u201322782. https:\/\/doi.org\/10.1021\/acsomega.3c01681","journal-title":"ACS Omega"},{"key":"2346_CR56","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/geroni\/igad104.1555","volume":"7","author":"R Fan","year":"2023","unstructured":"Fan R (2023) Spatial omics for mapping cellular, senescence in health, aging and disease. Innov Aging, 7:473\u2013473. https:\/\/doi.org\/10.1093\/geroni\/igad104.1555","journal-title":"Innov Aging"},{"key":"2346_CR57","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a037341","author":"ME Fane","year":"2019","unstructured":"Fane ME, Weeraratna AT (2019a) Normal aging and its role in cancer metastasis. Cold Spring Harbor Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a037341","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"2","key":"2346_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"ME Fane","year":"2019","unstructured":"Fane ME, Weeraratna AT (2019b) How the ageing microenvironment influences tumour progression. Nat Rev Cancer 20(2):89\u2013106. https:\/\/doi.org\/10.1038\/s41568-019-0222-9","journal-title":"Nat Rev Cancer"},{"key":"2346_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.979116","author":"L Fang","year":"2022","unstructured":"Fang L, Liu K, Liu C, Wang X, Ma W, Xu W, Wu J, Sun C (2022) Tumor accomplice: T cell exhaustion induced by chronic inflammation. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.979116","journal-title":"Frontiers Immunology 13 Front Media"},{"issue":"2","key":"2346_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.14715\/cmb\/2021.67.2.28","volume":"67","author":"AA Farooq\u0131","year":"2021","unstructured":"Farooq\u0131 AA, Tahir F, Fakhar M, Butt G, Pimentel TC, Wu N, Ishmuratova M, Attar R (2021) Antimetastatic effects of Citrus-derived bioactive ingredients: mechanistic insights. Cell Mol Biol 67(2):178\u2013186. https:\/\/doi.org\/10.14715\/cmb\/2021.67.2.28","journal-title":"Cell Mol Biol"},{"key":"2346_CR62","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10171","author":"X Feng","year":"2019","unstructured":"Feng X, Su X (2019) Anticancer effect of ursolic acid via mitochondria\u2013dependent pathways (Review). Oncol Lett. https:\/\/doi.org\/10.3892\/ol.2019.10171. Review of Anticancer effect of ursolic acid via mitochondria\u2013dependent pathways (Review). Spandidos Publishing","journal-title":"Oncol Lett"},{"issue":"1","key":"2346_CR61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12943-025-02419-2","volume":"24","author":"T Feng","year":"2025","unstructured":"Feng T, Xie F, Lee LM-Y, Lin Z, Tu Y, Lyu Y, Yu P, Wu J, Chen B, Zhang G, Tse GM, To K, Kang W (2025) Cellular senescence in cancer: from mechanism paradoxes to precision therapeutics. Mol Cancer 24(1):213\u2013213. https:\/\/doi.org\/10.1186\/s12943-025-02419-2","journal-title":"Mol Cancer"},{"key":"2346_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10460-1","author":"H Fleury","year":"2019","unstructured":"Fleury H, Malaquin N, Tu V, Gilbert S, Martinez A, Olivier M, Sauriol SA, Communal L, Leclerc-Desaulniers K, Carmona E, Provencher D, Mes-Masson A, Rodier F (2019) Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-10460-1","journal-title":"Nat Commun"},{"issue":"6","key":"2346_CR64","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.3892\/ijmm.2018.3531","volume":"41","author":"H Fu","year":"2018","unstructured":"Fu H, Li C, Chen X, Liu X (2018) Daidzein exerts anticancer activity towards SKOV3 human ovarian cancer cells by inducing apoptosis and cell cycle arrest, and inhibiting the Raf\/MEK\/ERK cascade. Int J Mol Med 41(6):3485\u20133492. https:\/\/doi.org\/10.3892\/ijmm.2018.3531","journal-title":"Int J Mol Med"},{"key":"2346_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02371-z","author":"Y Fu","year":"2025","unstructured":"Fu Y, Wang B, Alu A, Hong W, Hong L, He X, Cheng HS, Yang P X (2025) Immunosenescence: signalling pathways, diseases and therapeutic targets. Signal Transduct Target Therapy https:\/\/doi.org\/10.1038\/s41392-025-02371-z","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1192714","author":"L Gao","year":"2023","unstructured":"Gao L, Liu X, Luo X, Lou X, Li P, Li X, Liu X (2023) Antiaging effects of dietary supplements and natural products. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1192714","journal-title":"Frontiers Pharmacology 14 Front Media"},{"issue":"9","key":"2346_CR67","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1021\/acs.accounts.3c00794","volume":"57","author":"J Garc\u00eda-Fleitas","year":"2024","unstructured":"Garc\u00eda-Fleitas J, Garc\u00eda-Fern\u00e1ndez A, Mart\u00ed\u2010Centelles V, Sancen\u00f3n F, Bernardos A, Mart\u00ednez\u2010M\u00e1\u00f1ez R (2024) Chemical strategies for the detection and elimination of senescent cells. Acc Chem Res 57(9):1238\u20131253. https:\/\/doi.org\/10.1021\/acs.accounts.3c00794","journal-title":"Acc Chem Res"},{"key":"2346_CR68","doi-asserted-by":"publisher","first-page":"1565278","DOI":"10.3389\/fimmu.2025.1565278","volume":"16","author":"M Gergues","year":"2025","unstructured":"Gergues M, Bari R, Koppisetti S, Gosiewska A, Kang L, Hariri R (2025) Senescence, NK cells, and cancer: navigating the crossroads of aging and disease. Front Immunol 16:1565278\u20131565278. https:\/\/doi.org\/10.3389\/fimmu.2025.1565278","journal-title":"Front Immunol"},{"issue":"10","key":"2346_CR69","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3390\/nu11102376","volume":"11","author":"A Giordano","year":"2019","unstructured":"Giordano A, Tommonaro G (2019) Curcumin and Cancer. Nutrients 11(10):2376\u20132376. https:\/\/doi.org\/10.3390\/nu11102376","journal-title":"Nutrients"},{"key":"2346_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KC-Y, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, Kulke MH, Baird RD, Prabhu JS, Carbone D, Pecoraro C, Teh DBL, Sethi G, Cavalieri V, Lin K, Kumar AP (2023) PI3K\/AKT\/mTOR signalling transduction pathway and targeted therapies in cancer. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-023-01827-6","journal-title":"Mol Cancer"},{"key":"2346_CR72","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13142","author":"E Gonz\u00e1lez-Gualda","year":"2020","unstructured":"Gonz\u00e1lez-Gualda E, P\u00e0ez\u2010Ribes M, Lozano\u2010Torres B, Mac\u00edas D, Wilson JR, Gonz\u00e1lez\u2010L\u00f3pez C, Ou H, Mir\u00f3n\u2010Barroso S, Zhang Z, L\u00e9rida\u2010Viso A, Blandez JF, Bernardos A, Sancen\u00f3n F, Rovira M, Fruk L, Martins CP, Serrano M, Doherty GJ, Mart\u00ednez\u2010M\u00e1\u00f1ez R, Mu\u00f1oz\u2010Esp\u00edn D (2020) Galacto\u2010conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity. Aging Cell. https:\/\/doi.org\/10.1111\/acel.13142","journal-title":"Aging Cell"},{"key":"2346_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00971-6","author":"M Govindarajan","year":"2020","unstructured":"Govindarajan M, Wohlmuth C, Waas M, Bernardini MQ, Kislinger T (2020) High-throughput approaches for precision medicine in high-grade serous ovarian cancer. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-020-00971-6","journal-title":"J Hematol Oncol"},{"issue":"11","key":"2346_CR74","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s42255-019-0122-z","volume":"1","author":"A Guerrero","year":"2019","unstructured":"Guerrero A, Herranz N, Sun B, Wagner V, Gallage S, Guiho R, Wolter K, Pombo J, Irvine EE, Innes AJ, Birch J, Glegola J, Manshaei S, Heide D, Dharmalingam G, Harbig J, Olona A, Behmoaras J, Dauch D, Gil J (2019) Cardiac glycosides are broad-spectrum senolytics. Nat Metabolism 1(11):1074\u20131088. https:\/\/doi.org\/10.1038\/s42255-019-0122-z","journal-title":"Nat Metabolism"},{"key":"2346_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-018-0398-2","author":"X Guo","year":"2018","unstructured":"Guo X, Cheng Y, Zhao X, Luo Y, Chen J, Yuan W (2018) Advances in redox-responsive drug delivery systems of tumor microenvironment. J Nanobiotechnol. https:\/\/doi.org\/10.1186\/s12951-018-0398-2","journal-title":"J Nanobiotechnol"},{"key":"2346_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01251-0","author":"J Guo","year":"2022","unstructured":"Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, Li J (2022) Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-022-01251-0","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01757-9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, Zeng C, Zhou T, Zhang J (2024) NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-024-01757-9","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02160","author":"SC Gupta","year":"2018","unstructured":"Gupta SC, Kunnumakkara AB, Aggarwal S, Aggarwal BB (2018) Inflammation, a double-edge sword for cancer and other age-related diseases. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.02160","journal-title":"Frontiers Immunology 9 Front Media"},{"key":"2346_CR79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.arr.2018.05.001","volume":"46","author":"F Gur\u0103u","year":"2018","unstructured":"Gur\u0103u F, Baldoni S, Prattichizzo F, Espinosa E, Amenta F, Procopio AD, Albertini MC, Bonaf\u00e8 M, Olivieri F (2018) Anti-senescence compounds: a potential nutraceutical approach to healthy aging. Ageing Res Rev 46:14\u201331. https:\/\/doi.org\/10.1016\/j.arr.2018.05.001","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2346_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-022-00906-w","volume":"55","author":"Y Han","year":"2023","unstructured":"Han Y, Kim SY (2023) Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics. Exp Mol Med 55(1):1\u201312. https:\/\/doi.org\/10.1038\/s12276-022-00906-w","journal-title":"Exp Mol Med"},{"issue":"7","key":"2346_CR81","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/cancers10070230","volume":"10","author":"EI Harper","year":"2018","unstructured":"Harper EI, Sheedy E, Stack MS (2018) With great age comes great metastatic ability: ovarian cancer and the appeal of the aging peritoneal microenvironment. Cancers 10(7):230\u2013230. https:\/\/doi.org\/10.3390\/cancers10070230","journal-title":"Cancers"},{"issue":"1","key":"2346_CR83","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3892\/or.2015.4354","volume":"35","author":"Z He","year":"2015","unstructured":"He Z, Chen Y, Rojanasakul A, Rankin YO, G., Chen C, Y (2015) Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN\/AKT\/HIF-1\u03b1\/VEGF signalling pathway in ovarian cancer cells. Oncol Rep 35(1):291\u2013297. https:\/\/doi.org\/10.3892\/or.2015.4354","journal-title":"Oncol Rep"},{"key":"2346_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15838-0","author":"Y He","year":"2020","unstructured":"He Y, Zhang X, Chang J, Kim H, Zhang P, Wang Y, Khan S, Liu X, Zhang X, Lv D, Song L, Li W, Thummuri D, Yuan Y, Wiegand J, Ortiz YT, Budamagunta V, Elisseeff JH, Campisi J, Zhou D (2020) Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-020-15838-0","journal-title":"Nat Commun"},{"issue":"9","key":"2346_CR84","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/ncb3225","volume":"17","author":"N Herranz","year":"2015","unstructured":"Herranz N, Gallage S, Mellone M, W\u00fcestefeld T, Klotz S, Hanley CJ, Raguz S, Acosta JC, Innes AJ, Banito A, Georgilis A, Montoya A, Wolter K, Dharmalingam G, Faull P, Carroll T, Mart\u0131\u0301nez-Barber\u00e1 JP, Cutillas PR, Reisinger F, Gil J (2015) mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat Cell Biol 17(9):1205\u20131217. https:\/\/doi.org\/10.1038\/ncb3225","journal-title":"Nat Cell Biol"},{"key":"2346_CR85","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","volume":"47","author":"LJ Hickson","year":"2019","unstructured":"Hickson LJ, Prata L, Bobart SA, Evans TK, Giorgadze N, Hashmi S, Herrmann SM, Jensen MD, Jia Q, Jordan KL, Kellogg TA, Khosla S, Koerber DM, Lagnado AB, Lawson DK, LeBrasseur NK, Lerman LO, McDonald KM, McKenzie TJ, Kirkland JL (2019) Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine 47:446\u2013456. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.069","journal-title":"EBioMedicine"},{"key":"2346_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01767-7","author":"R Hosea","year":"2024","unstructured":"Hosea R, Hillary S, Naqvi SHR, Wu S, Kasim V (2024) The two sides of chromosomal instability: drivers and brakes in cancer. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-024-01767-7","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR88","doi-asserted-by":"publisher","DOI":"10.4172\/2576-1471.1000104","author":"X Hou","year":"2016","unstructured":"Hou X, Yang F, Liu W, Fu Z, Chen L, Li Z, Ni C, Liu M, Cao G (2016) Signalling pathways that facilitate chronic inflammation-induced carcinogenesis. J Cell Signal. https:\/\/doi.org\/10.4172\/2576-1471.1000104","journal-title":"J Cell Signal"},{"key":"2346_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.471","author":"D Hou","year":"2017","unstructured":"Hou D, Xu G, Zhang C, Li B, Qin J, Hao X, Liu Q, Zhang X, Liu J, Wei J, Gong Y, Liu Z, Shao C (2017) Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition. Cell Death Dis. https:\/\/doi.org\/10.1038\/cddis.2017.471","journal-title":"Cell Death Dis"},{"key":"2346_CR89","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7419","author":"C Hsiao","year":"2019","unstructured":"Hsiao C, Yao C, Lai G, Lee L, Whang-Peng J, Shih P (2019) Honokiol induces apoptotic cell death by oxidative burst and mitochondrial hyperpolarization of bladder cancer cells. Exp Therapeutic Med. https:\/\/doi.org\/10.3892\/etm.2019.7419","journal-title":"Experimental Therapeutic Med"},{"key":"2346_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signalling pathway: from bench to clinic. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-021-00791-1","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2265-6","author":"J-S Huang","year":"2016","unstructured":"Huang J-S, Yao C, Chuang S, Yeh C, Lee L-M, Chen R, Chao W-J, Whang-Peng J, Lai G (2016) Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK\/STAT signalling pathway suppression and apoptosis induction. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-016-2265-6","journal-title":"BMC Cancer"},{"key":"2346_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0166-5","author":"K Huang","year":"2018","unstructured":"Huang K, Chen Y, Zhang R, Wu Y, Ma Y, Fang X, Shen S (2018) Honokiol induces apoptosis and autophagy via the ROS\/ERK1\/2 signalling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-017-0166-5","journal-title":"Cell Death Dis"},{"key":"2346_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00836","author":"L Huang","year":"2020","unstructured":"Huang L, Peng B, Nayak Y, Wang C, Si F, Liu X, Dou J, Xu H, Peng G (2020) Baicalein and baicalin promote melanoma apoptosis and senescence via metabolic inhibition. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2020.00836","journal-title":"Front Cell Dev Biol"},{"issue":"46","key":"2346_CR91","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1038\/s41388-021-02055-2","volume":"40","author":"D Huang","year":"2021","unstructured":"Huang D, Savage SR, Calinawan A, Lin C, Zhang B, Wang P, Starr TK, Birrer MJ, Paulovich AG (2021) A highly annotated database of genes associated with platinum resistance in cancer. Oncogene 40(46):6395\u20136405. https:\/\/doi.org\/10.1038\/s41388-021-02055-2","journal-title":"Oncogene"},{"key":"2346_CR95","doi-asserted-by":"publisher","unstructured":"Iborra FJ, Mart\u00ed C, Calabuig-Navarro V, Papadopoulos P, Meseguer S, Iborra PM, Garc\u00eda-Garc\u00eda F, Mart\u00ednez-Lorente A, Almaz\u00e1n F, Calabuig J (2023), July 3 Chemotherapy induces cell plasticity; controlling plasticity increases therapeutic response. In: Signal Transduction and Targeted Therapy (Vol. 8, Issue 1). Springer Nature. https:\/\/doi.org\/10.1038\/s41392-023-01500-w","DOI":"10.1038\/s41392-023-01500-w"},{"issue":"5","key":"2346_CR96","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1002\/ptr.6977","volume":"35","author":"A Imani","year":"2020","unstructured":"Imani A, Maleki ND, Bohlouli S, Kouhsoltani M, Sharifi S, Dizaj SM (2020) Molecular mechanisms of anticancer effect of rutin. Phytother Res 35(5):2500\u20132513. https:\/\/doi.org\/10.1002\/ptr.6977","journal-title":"Phytother Res"},{"issue":"5","key":"2346_CR97","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/pharmaceutics12050439","volume":"12","author":"A Isabel Fraguas-S\u00e1nchez","year":"2020","unstructured":"Isabel Fraguas-S\u00e1nchez A, Torres-Su\u00e1rez I, Cohen A, Deli\u00e9 M, Bastida-Ruiz F, Yart D, Mart\u00edn-Sabroso L, C., Fern\u00e1ndez-Carballido A (2020) PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: in vitro and. Ovo Assess Pharmaceutics 12(5):439\u2013439. https:\/\/doi.org\/10.3390\/pharmaceutics12050439","journal-title":"Ovo Assess Pharmaceutics"},{"key":"2346_CR98","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.semcancer.2022.02.022","volume":"86","author":"NK Jha","year":"2022","unstructured":"Jha NK, Arfin S, Jha SK, Kar R, Dey A, Gundamaraju R, Ashraf GM, Gupta PK, Dhanasekaran S, Abomughaid MM, Das SS, Singh SK, Dua K, Roychoudhury S, Kumar D, Ruokolainen J, Ojha S, Kesari KK (2022) Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signalling. Sem Cancer Biol 86:1086\u20131104. https:\/\/doi.org\/10.1016\/j.semcancer.2022.02.022","journal-title":"Sem Cancer Biol"},{"key":"2346_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01343-5","author":"S Ji","year":"2023","unstructured":"Ji S, Xiong M, Chen H, Liu Y, Zhou L, Hong Y, Wang M, Wang C, Fu X, Sun X (2023) Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-023-01343-5","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/mog2.70007","author":"P Jin","year":"2024","unstructured":"Jin P, Feng X, Huang C, Li J, Wang H, Wang X, Li L, Ma L (2024) Oxidative stress and cellular senescence: roles in tumor progression and therapeutic opportunities. MedComm Oncol. https:\/\/doi.org\/10.1002\/mog2.70007","journal-title":"MedComm Oncol"},{"key":"2346_CR101","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14178","author":"N Joma","year":"2024","unstructured":"Joma N, Bielawski P, Saini A, Kakkar A, Maysinger D (2024) Nanocarriers for natural polyphenol senotherapeutics. Aging Cell. https:\/\/doi.org\/10.1111\/acel.14178","journal-title":"Aging Cell"},{"key":"2346_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-020-00187-9","author":"A Kale","year":"2020","unstructured":"Kale A, Sharma A, Stolzing A, Desprez P, Campisi J (2020) Role of immune cells in the removal of deleterious senescent cells. Immun Ageing. https:\/\/doi.org\/10.1186\/s12979-020-00187-9","journal-title":"Immun Ageing"},{"issue":"4","key":"2346_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0238-y","volume":"51","author":"KA Kang","year":"2019","unstructured":"Kang KA, Piao MJ, Hyun YJ, Zhen AX, Cho SJ, Ahn MJ, Yi JM, Hyun JW (2019) Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells. Exp Mol Med 51(4):1\u201314. https:\/\/doi.org\/10.1038\/s12276-019-0238-y","journal-title":"Exp Mol Med"},{"issue":"1","key":"2346_CR104","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10787-024-01635-4","volume":"33","author":"G Kannan","year":"2025","unstructured":"Kannan G, Paul BM, Thangaraj P (2025) Stimulation, regulation, and inflammaging interventions of natural compounds on nuclear factor kappa B (NF-kB) pathway: a comprehensive review. Inflammopharmacology 33(1):145\u2013162. https:\/\/doi.org\/10.1007\/s10787-024-01635-4","journal-title":"Inflammopharmacology"},{"issue":"5","key":"2346_CR105","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1039\/c5cs00798d","volume":"45","author":"M Karimi","year":"2016","unstructured":"Karimi M, Ghasemi A, Zangabad PS, Rahighi R, Basri SMM, Mirshekari H, Amiri MS, Shafaei Z, Aslani A, Bozorgomid M, Ghosh D, Beyzavi A, Vaseghi A, Aref AR, Haghani L, Bahrami S, Hamblin MR (2016) Smart micro\/nanoparticles in stimulus-responsive drug\/gene delivery systems. Chem Soc Rev 45(5):1457\u20131501. https:\/\/doi.org\/10.1039\/c5cs00798d","journal-title":"Chem Soc Rev"},{"issue":"1","key":"2346_CR107","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5483\/bmbrep.2019.52.1.293","volume":"52","author":"E-C Kim","year":"2019","unstructured":"Kim E-C, Kim J (2019) Senotherapeutics: emerging strategy for healthy aging and age-related disease. BMB Rep 52(1):47\u201355. https:\/\/doi.org\/10.5483\/bmbrep.2019.52.1.293","journal-title":"BMB Rep"},{"key":"2346_CR108","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jnutbio.2015.09.014","volume":"33","author":"H Kim","year":"2015","unstructured":"Kim H, Ramirez CN, Su Z, Kong AT (2015) Epigenetic modifications of triterpenoid ursolic acid in activating Nrf2 and blocking cellular transformation of mouse epidermal cells. J Nutr Biochem 33:54\u201362. https:\/\/doi.org\/10.1016\/j.jnutbio.2015.09.014","journal-title":"J Nutr Biochem"},{"key":"2346_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01053-x","author":"B Kim","year":"2021","unstructured":"Kim B, Malek E, Choi SH, Ignatz-Hoover JJ, Driscoll JJ (2021) Novel therapies emerging in oncology to target the TGF-\u03b2 pathway. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-021-01053-x","journal-title":"J Hematol Oncol"},{"issue":"4","key":"2346_CR109","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrc3432","volume":"13","author":"E Kipps","year":"2013","unstructured":"Kipps E, Tan DSP, Kaye SB (2013) Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer 13(4):273\u2013282. https:\/\/doi.org\/10.1038\/nrc3432","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2346_CR110","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/joim.13141","volume":"288","author":"JL Kirkland","year":"2020","unstructured":"Kirkland JL, Tchkonia T (2020) Senolytic drugs: from discovery to translation. J Intern Med 288(5):518\u2013536. https:\/\/doi.org\/10.1111\/joim.13141","journal-title":"J Intern Med"},{"issue":"1","key":"2346_CR111","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10555-023-10134-x","volume":"43","author":"P Kubatka","year":"2023","unstructured":"Kubatka P, Koklesov\u00e1 L, Mazur\u00e1kov\u00e1 A, Brockmueller A, B\u00fcsselberg D, Kello M, Shakibaei M (2023) Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signalling. Cancer Metastasis Rev 43(1):87\u2013113. https:\/\/doi.org\/10.1007\/s10555-023-10134-x","journal-title":"Cancer Metastasis Rev"},{"key":"2346_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.650772","author":"V Kumar","year":"2021","unstructured":"Kumar V, Vashishta M, Kong L, Wu X, Lu JJ, Guha C, Dwarakanath BS (2021) The Role of notch, hedgehog, and wnt signalling pathways in the resistance of tumors to anticancer therapies. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.650772","journal-title":"Front Cell Dev Biology"},{"issue":"2","key":"2346_CR113","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10585-021-10077-z","volume":"38","author":"A Kumari","year":"2021","unstructured":"Kumari A, Shonibare Z, Monavarian M, Arend RC, Lee NY, Inman GJ, Mythreye K (2021) TGF\u03b2 signalling networks in ovarian cancer progression and plasticity. Clin Exp Metastasis 38(2):139\u2013161. https:\/\/doi.org\/10.1007\/s10585-021-10077-z","journal-title":"Clin Exp Metastasis"},{"key":"2346_CR114","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.freeradbiomed.2021.05.003","volume":"171","author":"SM Lagoumtzi","year":"2021","unstructured":"Lagoumtzi SM, Chondrogianni N (2021) Senolytics and senomorphics: natural and synthetic therapeutics in the treatment of aging and chronic diseases. Free Radic Biol Med 171:169\u2013190. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.05.003","journal-title":"Free Radic Biol Med"},{"key":"2346_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-147","author":"V Lavou\u00e9","year":"2013","unstructured":"Lavou\u00e9 V, Thedrez A, L\u00e9v\u00eaque J, Foucher F, Henno S, Jauffret V, Belaud-Rotureau M, Catros V, Cabillic F (2013) Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer. J Trans Med. https:\/\/doi.org\/10.1186\/1479-5876-11-147","journal-title":"J Translational Med"},{"key":"2346_CR116","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2019.4122","author":"J Lee","year":"2019","unstructured":"Lee J, Sul JY, Park J, Lee M, Cha E, Ko YG (2019) Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK\/mTOR signalling pathway. Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2019.4122","journal-title":"Int J Mol Med"},{"key":"2346_CR117","doi-asserted-by":"publisher","first-page":"117672","DOI":"10.1016\/j.bcp.2026.117672","volume":"245","author":"W Lee","year":"2026","unstructured":"Lee W, Song G, Bae H (2026) Chlorogenic acid attenuates endometrial senescence via mTOR modulation: a combined network pharmacology, in vitro, and in vivo study. Biochem Pharmacol 245:117672\u2013117672. https:\/\/doi.org\/10.1016\/j.bcp.2026.117672","journal-title":"Biochem Pharmacol"},{"key":"2346_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-024-00138-4","author":"V Lelarge","year":"2024","unstructured":"Lelarge V, Capelle R, Oger F, Mathieu T, Calv\u00e9 BL (2024) Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients\u2019 treatment. Npj Aging. https:\/\/doi.org\/10.1038\/s41514-024-00138-4","journal-title":"Npj Aging"},{"issue":"6","key":"2346_CR119","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s10495-017-1353-7","volume":"22","author":"A Lewi\u0144ska","year":"2017","unstructured":"Lewi\u0144ska A, Adamczyk-Grochala J, Kwasniewicz E, Der\u0119gowska A, Wnuk M (2017) Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells. Apoptosis 22(6):800\u2013815. https:\/\/doi.org\/10.1007\/s10495-017-1353-7","journal-title":"Apoptosis"},{"key":"2346_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2016.71","author":"J Li","year":"2016","unstructured":"Li J, Mooney D (2016) Designing hydrogels for controlled drug delivery. Nat Rev Mater. https:\/\/doi.org\/10.1038\/natrevmats.2016.71","journal-title":"Nat Reviews Mater"},{"key":"2346_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00315-4","author":"B Li","year":"2017","unstructured":"Li B, Hou D, Guo H, Zhou H, Zhang S, Xu X, Liu Q, Zhang X, Zou Y, Gong Y, Shao C (2017) Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-00315-4","journal-title":"Sci Rep"},{"issue":"1","key":"2346_CR123","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/molecules27010078","volume":"27","author":"L Li","year":"2021","unstructured":"Li L, Pan Z, Ning D-S, Fu Y (2021) Rosmanol and carnosol synergistically alleviate rheumatoid arthritis through inhibiting TLR4\/NF-\u03baB\/MAPK pathway. Molecules 27(1):78\u201378. https:\/\/doi.org\/10.3390\/molecules27010078","journal-title":"Molecules"},{"key":"2346_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01502-8","author":"X Li","year":"2023","unstructured":"Li X, Li C, Zhang W, Wang Y, Qian P, Huang H (2023) Inflammation and aging: signalling pathways and intervention therapies. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-023-01502-8","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR121","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaf631.058","author":"CS Li","year":"2025","unstructured":"Li CS, Liu Z, Yu S, Liang Q, Song Y, Zhao Q, Gong L (2025a) Estrogen signalling and senescence-associated secretory phenotype in ovarian cancer: remodelling the tumor immune microenvironment and therapy response. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbaf631.058","journal-title":"Brief Bioinform"},{"key":"2346_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101492","author":"X Li","year":"2025","unstructured":"Li X, Li X, Ni S, Zhang X, Liu B (2025b) Immunocyte senescence: a new perspective on the remodelling of the ovarian cancer microenvironment and therapeutic intervention. J Pharm Anal. https:\/\/doi.org\/10.1016\/j.jpha.2025.101492","journal-title":"J Pharm Anal"},{"key":"2346_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00986-z","author":"J Lian","year":"2020","unstructured":"Lian J, Yue Y, Yu W, Zhang Y (2020) Immunosenescence: a key player in cancer development. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-020-00986-z","journal-title":"J Hematol Oncol"},{"issue":"48","key":"2346_CR128","doi-asserted-by":"publisher","first-page":"9180","DOI":"10.1021\/acs.jafc.6b04147","volume":"64","author":"R Liang","year":"2016","unstructured":"Liang R, Chen L, Yokoyama W, Williams PA, Zhong F (2016) Niosomes consisting of tween-60 and cholesterol improve the chemical stability and antioxidant activity of (\u2013)-epigallocatechin gallate under intestinal tract conditions. J Agric Food Chem 64(48):9180\u20139188. https:\/\/doi.org\/10.1021\/acs.jafc.6b04147","journal-title":"J Agric Food Chem"},{"key":"2346_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1186712","author":"D Liang","year":"2023","unstructured":"Liang D, Liu L, Zhao Y, Luo Z, He Y, Li Y, Tang S, Tang J, Chen N (2023) Targeting extracellular matrix through phytochemicals: a promising approach of multi-step actions on the treatment and prevention of cancer. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1186712","journal-title":"Frontiers Pharmacology 14 Front Media"},{"issue":"10","key":"2346_CR129","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3390\/ijms17101681","volume":"17","author":"H Liu","year":"2016","unstructured":"Liu H, Dong Y, Gao Y, Du Z, Wang Y, Cheng P, Chen A, Huang H (2016) The fascinating effects of baicalein on cancer: a review. Int J Mol Sci 17(10):1681\u20131681. https:\/\/doi.org\/10.3390\/ijms17101681","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2346_CR131","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1080\/15384047.2017.1394542","volume":"18","author":"H Liu","year":"2017","unstructured":"Liu H, Zeng Z, Wang S, Li T, Mastriani E, Li Q, Bao H, Zhou Y, Wang X, Liu Y, Liu W, Hu S, Gao S, Yu M, Qi Y, Shen Z, Wang H, Gao T, Dong L, Liu S (2017) Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9. Cancer Biol Ther 18(12):990\u2013999. https:\/\/doi.org\/10.1080\/15384047.2017.1394542","journal-title":"Cancer Biol Ther"},{"issue":"14","key":"2346_CR134","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1016\/j.bmc.2018.06.013","volume":"26","author":"X Liu","year":"2018","unstructured":"Liu X, Wang Y, Zhang X, Gao Z, Zhang S, Shi P, Zhang X, Song L, Hendrickson HP, Zhou D, Zheng G (2018) Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation. Bioorg Med Chem 26(14):3925\u20133938. https:\/\/doi.org\/10.1016\/j.bmc.2018.06.013","journal-title":"Bioorg Med Chem"},{"key":"2346_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00436-9","author":"S Liu","year":"2021","unstructured":"Liu S, Ren J, Dijke P (2021) Targeting TGF\u03b2 signal transduction for cancer therapy. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-020-00436-9","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR130","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13921","author":"H Liu","year":"2023","unstructured":"Liu H, Xu Q, Wufuer H, Li Z, Sun R, Jiang Z, Dou X, Fu Q, Campisi J, Sun Y (2023a) Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy. Aging Cell. https:\/\/doi.org\/10.1111\/acel.13921","journal-title":"Aging Cell"},{"key":"2346_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01451-2","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, Cheng Q, Luo P, Zhang Y, Han X (2023b) Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-023-01451-2","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR135","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2311028121","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liu X, Chen X, Yang Z, Chen J, Zhu W, Li Y, Wen Y, Deng C, Gu C, Lv J, Ju R, Zhuo Y, Su W (2024) Senolytic and senomorphic agent procyanidin C1 alleviates structural and functional decline in the aged retina. Proc Natl Acad Sci. https:\/\/doi.org\/10.1073\/pnas.2311028121","journal-title":"Proc Natl Acad Sci"},{"key":"2346_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01735-w","author":"Q Liu","year":"2025","unstructured":"Liu Q, Li J, Sun X, Lin J, Yu Z, Xiao Y, Li D, Sun B, Bao H, Liu Y (2025) Immunosenescence and cancer: molecular hallmarks, tumor microenvironment remodelling, and age-specific immunotherapy challenges. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-025-01735-w","journal-title":"J Hematol Oncol"},{"issue":"2","key":"2346_CR137","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbcan.2016.01.007","volume":"1865","author":"N Loaiza","year":"2016","unstructured":"Loaiza N, Demaria M (2016) Cellular senescence and tumor promotion: Is aging the key?. Biochimica et Biophysica Acta (BBA) - Rev Cancer. 1865(2):155\u2013167. https:\/\/doi.org\/10.1016\/j.bbcan.2016.01.007","journal-title":"Biochimica et Biophysica Acta (BBA) - Rev Cancer"},{"issue":"8","key":"2346_CR138","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1021\/acs.molpharmaceut.9b00136","volume":"16","author":"P Lu","year":"2019","unstructured":"Lu P, Bowman KER, Brown SM, Joklik-Mcleod M, Mause ERV, Nguyen HTN, Lim CS (2019) p53-bad: a novel tumor suppressor\/proapoptotic factor hybrid directed to the mitochondria for ovarian cancer gene therapy. Mol Pharm 16(8):3386\u20133398. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00136","journal-title":"Mol Pharm"},{"issue":"4","key":"2346_CR139","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1124\/pharmrev.122.000622","volume":"75","author":"V Lucas","year":"2023","unstructured":"Lucas V, Cavadas C, Aveleira CA (2023) Cellular senescence: from mechanisms to current biomarkers and senotherapies. Pharmacol Rev 75(4):675\u2013713. https:\/\/doi.org\/10.1124\/pharmrev.122.000622","journal-title":"Pharmacol Rev"},{"key":"2346_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-10-16","author":"H Luo","year":"2010","unstructured":"Luo H, Daddysman MK, Rankin GO, Jiang B, Chen Y (2010) Kaempferol enhances cisplatin\u2019s effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc. Cancer Cell Int. https:\/\/doi.org\/10.1186\/1475-2867-10-16","journal-title":"Cancer Cell Int"},{"issue":"2","key":"2346_CR141","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.foodchem.2011.07.045","volume":"130","author":"H Luo","year":"2011","unstructured":"Luo H, Rankin GO, Juliano N, Jiang B, Chen Y (2011) Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NF\u03baB-cMyc-p21 pathway. Food Chem 130(2):321\u2013328. https:\/\/doi.org\/10.1016\/j.foodchem.2011.07.045","journal-title":"Food Chem"},{"key":"2346_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0638-3","author":"M Lupia","year":"2017","unstructured":"Lupia M, Cavallaro U (2017) Ovarian cancer stem cells: still an elusive entity? Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-017-0638-3","journal-title":"Mol Cancer"},{"key":"2346_CR143","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-024-00625-9","author":"J Lv","year":"2024","unstructured":"Lv J, Jin S, Zhang Y, Zhou Y, Li M, Feng N (2024) Equol: a metabolite of gut microbiota with potential antitumor effects. Gut Pathogens. https:\/\/doi.org\/10.1186\/s13099-024-00625-9","journal-title":"Gut Pathogens"},{"issue":"3","key":"2346_CR145","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2016.171","volume":"18","author":"J de Maciejowski","year":"2017","unstructured":"Maciejowski J, de Lange T (2017) Telomeres in cancer: tumour suppression and genome instability. Nat Rev Mol Cell Biol 18(3):175\u2013186. https:\/\/doi.org\/10.1038\/nrm.2016.171","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"2346_CR146","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/clinpract13040076","volume":"13","author":"S Malayaperumal","year":"2023","unstructured":"Malayaperumal S, Marotta F, Kumar MM, Somasundaram I, Ayala A, Pinto MM, Banerjee A, Pathak S (2023) The emerging role of senotherapy in cancer: a comprehensive review. Clin Pract 13(4):838\u2013852. https:\/\/doi.org\/10.3390\/clinpract13040076","journal-title":"Clin Pract"},{"issue":"9","key":"2346_CR147","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1021\/acs.jnatprod.3c00186","volume":"86","author":"AC Maldonado","year":"2023","unstructured":"Maldonado AC, Haughan MA, Khin M, Ekiert J, Zhang Z, Lantvit DD, Subeh ZYA, Pierre HC, Salkovski M, Hirschhorn T, Gao Y, Pearce CJ, Stockwell BR, Aldrich LN, Oberlies NH, Burdette JE (2023) Probing the Cytotoxic Signalling Induced by Eupenifeldin in Ovarian Cancer Models. J Nat Prod 86(9):2102\u20132110. https:\/\/doi.org\/10.1021\/acs.jnatprod.3c00186","journal-title":"J Nat Prod"},{"key":"2346_CR148","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2676307","author":"M Man","year":"2019","unstructured":"Man M, Yang B, Elias PM (2019) Benefits of hesperidin for cutaneous functions. Evidence-Based Complement Altern Med. https:\/\/doi.org\/10.1155\/2019\/2676307","journal-title":"Evidence-Based Complement Altern Med"},{"issue":"1","key":"2346_CR149","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41514-024-00181-1","volume":"10","author":"LE Mansfield","year":"2024","unstructured":"Mansfield LE, Ramponi V, Gupta K, Stevenson T, Mathew AB, Barinda AJ, Herbstein F, Morsli S (2024) Emerging insights in senescence: pathways from preclinical models to therapeutic innovations. Npj Aging 10(1):53\u201353. https:\/\/doi.org\/10.1038\/s41514-024-00181-1","journal-title":"Npj Aging"},{"issue":"3","key":"2346_CR150","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10522-021-09915-0","volume":"22","author":"G Matacchione","year":"2021","unstructured":"Matacchione G, Gur\u0103u F, Silvestrini A, Tiboni M, Mancini L, Valli D, Rippo MR, Recchioni R, Marcheselli F, Carnevali O, Procopio AD, Casettari L, Olivieri F (2021) Anti-SASP and anti-inflammatory activity of resveratrol, curcumin and \u03b2-caryophyllene association on human endothelial and monocytic cells. Biogerontology 22(3):297\u2013313. https:\/\/doi.org\/10.1007\/s10522-021-09915-0","journal-title":"Biogerontology"},{"key":"2346_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1198-8","author":"M Mazzoni","year":"2019","unstructured":"Mazzoni M, Mauro G, Erreni M, Romeo P, Minna E, Vizioli MG, Belgiovine C, Rizzetti MG, Pagliardini S, Avigni R, Anania MC, Allavena P, Borrello MG, Greco A (2019) Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism. J Experimental Clin Cancer Res. https:\/\/doi.org\/10.1186\/s13046-019-1198-8","journal-title":"J Experimental Clin Cancer Res"},{"key":"2346_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02854-5","author":"S Mei","year":"2023","unstructured":"Mei S, Chen X, Wang K, Chen Y (2023) Tumor microenvironment in ovarian cancer peritoneal metastasis. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-023-02854-5","journal-title":"Cancer Cell Int"},{"issue":"5","key":"2346_CR153","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1039\/c8np00062j","volume":"36","author":"P Mena","year":"2018","unstructured":"Mena P, Bresciani L, Brindani N, Ludwig IA, Pereira-Caro G, Angelino D, Llorach R, Calani L, Brighenti F, Clifford MN, Gill CIR, Crozier A, Curti C, Rio DD (2018) Phenyl-\u03b3-valerolactones and phenylvaleric acids, the main colonic metabolites of flavan-3-ols: synthesis, analysis, bioavailability, and bioactivity. Nat Prod Rep 36(5):714\u2013752. https:\/\/doi.org\/10.1039\/c8np00062j","journal-title":"Nat Prod Rep"},{"issue":"3","key":"2346_CR154","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00018-017-2663-1","volume":"75","author":"J Miku\u0142a-Pietrasik","year":"2017","unstructured":"Miku\u0142a-Pietrasik J, Uruski P, Tykarski A, Ksi\u0105\u017cek K (2017) The peritoneal soil for a cancerous seed: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cell Mol Life Sci 75(3):509\u2013525. https:\/\/doi.org\/10.1007\/s00018-017-2663-1","journal-title":"Cell Mol Life Sci"},{"key":"2346_CR155","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2023.12968","author":"R Miky\u0161kov\u00e1","year":"2023","unstructured":"Miky\u0161kov\u00e1 R, Sapeg O, Psotka M, Novotny O, Hodn\u00fd Z, Balintova S, Mali\u0148\u00e1k D, Svobodov\u00e1 J, Andr\u00fds R, Rysanek D, Mus\u00edlek K, Reini\u0161 M (2023) STAT3 inhibitor Stattic and its analogues inhibit STAT3 phosphorylation and modulate cytokine secretion in senescent tumour cells. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2023.12968","journal-title":"Mol Med Rep"},{"issue":"5","key":"2346_CR156","doi-asserted-by":"publisher","first-page":"330","DOI":"10.18632\/aging.100556","volume":"5","author":"O Moiseeva","year":"2013","unstructured":"Moiseeva O, Desch\u00eanes-Simard X, Pollak M, Ferbeyre G (2013a) Metformin, aging and cancer. Aging 5(5):330\u2013331. https:\/\/doi.org\/10.18632\/aging.100556","journal-title":"Aging"},{"issue":"3","key":"2346_CR157","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/acel.12075","volume":"12","author":"O Moiseeva","year":"2013","unstructured":"Moiseeva O, Desch\u00eanes-Simard X, St\u2010Germain E, Igelmann S, Huot G, Cadar AE, Bourdeau V, Pollak M, Ferbeyre G (2013b) Metformin inhibits the senescence\u2010associated secretory phenotype by interfering with IKK\/NF\u2010\u03baB activation. Aging Cell 12(3):489\u2013498. https:\/\/doi.org\/10.1111\/acel.12075","journal-title":"Aging Cell"},{"issue":"3","key":"2346_CR158","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1039\/c0fo00132e","volume":"1","author":"M Monagas","year":"2010","unstructured":"Monagas M, Urp\u00ed-Sard\u00e1 M, S\u00e1nchez-Pat\u00e1n F, Llorach R, Garrido I, G\u00f3mez\u2010Cordov\u00e9s C, Andr\u00e9s\u2010Lacueva C, Bartolom\u00e9 B (2010) Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct 1(3):233\u2013233. https:\/\/doi.org\/10.1039\/c0fo00132e","journal-title":"Food Funct"},{"issue":"3","key":"2346_CR159","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3390\/ijms27031149","volume":"27","author":"SPSP Moura","year":"2026","unstructured":"Moura SPSP, Moreira VM, Salvador JAR (2026) Carnosic acid and its semisynthetic derivatives as promising anticancer agents. Int J Mol Sci 27(3):1149\u20131149. https:\/\/doi.org\/10.3390\/ijms27031149","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2346_CR160","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/antiox14070808","volume":"14","author":"H Murata","year":"2025","unstructured":"Murata H, Ogawa K, Yasui Y, Ochi T, Tomonobu N, Yamamoto K, Kinoshita R, Wada Y, Nakamura H, Nishibori M, Sakaguchi M (2025) Carnosol, a rosemary ingredient discovered in a screen for inhibitors of SARM1-NAD+ cleavage activity, ameliorates symptoms of peripheral neuropathy. Antioxidants 14(7):808\u2013808. https:\/\/doi.org\/10.3390\/antiox14070808","journal-title":"Antioxidants"},{"key":"2346_CR161","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neubiorev.2020.12.001","volume":"121","author":"C Musillo","year":"2020","unstructured":"Musillo C, Borgi M, Saul N, M\u00f6ller S, Luyten W, Berry A, Cirulli F (2020) Natural products improve healthspan in aged mice and rats: a systematic review and meta-analysis. Neurosci Biobehav Rev 121:89\u2013105. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.12.001","journal-title":"Neurosci Biobehavioral Reviews"},{"issue":"42","key":"2346_CR162","doi-asserted-by":"publisher","first-page":"38537","DOI":"10.1021\/acsami.9b14738","volume":"11","author":"PKB Nagesh","year":"2019","unstructured":"Nagesh PKB, Chowdhury P, Hatami E, Kumari S, Kashyap VK, Tripathi M, Wagh S, Meibohm B, Chauhan SC, Jaggi M, Yallapu MM (2019) Cross-linked polyphenol-based drug nano-self-assemblies engineered to blockade prostate cancer senescence. ACS Appl Mater Interfaces 11(42):38537\u201338554. https:\/\/doi.org\/10.1021\/acsami.9b14738","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"2346_CR163","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.3390\/ijms25105569","volume":"25","author":"V Naponelli","year":"2024","unstructured":"Naponelli V, Rocchetti MT, Mangieri D (2024) Apigenin: molecular mechanisms and therapeutic potential against cancer spreading. Int J Mol Sci 25(10):5569\u20135569. https:\/\/doi.org\/10.3390\/ijms25105569","journal-title":"Int J Mol Sci"},{"key":"2346_CR164","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-023-00365-y","author":"M Narwade","year":"2023","unstructured":"Narwade M, Shaikh A, Gajbhiye KR, Kesharwani P, Gajbhiye V (2023) Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery. Biomater Res. https:\/\/doi.org\/10.1186\/s40824-023-00365-y","journal-title":"Biomaterials Res"},{"issue":"5","key":"2346_CR165","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/medicina57050456","volume":"57","author":"U Natarajan","year":"2021","unstructured":"Natarajan U, Venkatesan T, Rathinavelu A (2021) Effect of the HDAC inhibitor on histone acetylation and methyltransferases in A2780 ovarian cancer cells. Medicina 57(5):456\u2013456. https:\/\/doi.org\/10.3390\/medicina57050456","journal-title":"Medicina"},{"issue":"7","key":"2346_CR166","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/gels9070523","volume":"9","author":"HT Nguyen","year":"2023","unstructured":"Nguyen HT, Chien TB, C\u01b0\u1eddng \u0110X (2023) Polymer-based hydrogels applied in drug delivery: an overview. Gels 9(7):523\u2013523. https:\/\/doi.org\/10.3390\/gels9070523","journal-title":"Gels"},{"issue":"10","key":"2346_CR170","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/antiox9100961","volume":"9","author":"EJ O\u2019Neill","year":"2020","unstructured":"O\u2019Neill EJ, Hartogh DJD, Azizi K, Tsiani E (2020) Anticancer properties of carnosol: a summary of in vitro and. Vivo Evid Antioxidants 9(10):961\u2013961. https:\/\/doi.org\/10.3390\/antiox9100961","journal-title":"Vivo Evid Antioxidants"},{"key":"2346_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1380194","author":"H-M Oh","year":"2024","unstructured":"Oh H-M, Cho C-K, Lee N, Son C (2024) Experimental evidence for anti-metastatic actions of apigenin: a mini review. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2024.1380194","journal-title":"Frontiers Oncology 14 Front Media"},{"key":"2346_CR168","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s266676","author":"M Omar","year":"2021","unstructured":"Omar M, Hasan OA, Zaki RM, Eleraky NE (2021) Externally triggered novel rapid-release sonosensitive folate-modified liposomes for gemcitabine: development and characteristics. Int J Nanomed. https:\/\/doi.org\/10.2147\/ijn.s266676","journal-title":"Int J Nanomed"},{"key":"2346_CR169","doi-asserted-by":"publisher","unstructured":"Omer A, Barrera MC, Moran JL, Lian XJ, Marco SD, Beaus\u00e9jour C, Gallouzi I (2020) G3BP1 controls the senescence-associated secretome and its impact on cancer progression. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-020-18734-9","DOI":"10.1038\/s41467-020-18734-9"},{"issue":"4","key":"2346_CR171","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.semcancer.2012.01.011","volume":"22","author":"S Ostrand-Rosenberg","year":"2012","unstructured":"Ostrand-Rosenberg S, Sinha P, Beury DW, Clements VK (2012) Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Sem Cancer Biol 22(4):275\u2013281. https:\/\/doi.org\/10.1016\/j.semcancer.2012.01.011","journal-title":"Sem Cancer Biol"},{"key":"2346_CR172","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.addr.2013.12.008","volume":"66","author":"B \u00d6zpolat","year":"2014","unstructured":"\u00d6zpolat B, Sood AK, L\u00f3pez-Berestein G (2014) Liposomal siRNA nanocarriers for cancer therapy. Adv Drug Deliv Rev 66:110\u2013116. https:\/\/doi.org\/10.1016\/j.addr.2013.12.008","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"2346_CR174","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/mnfr.201501007","volume":"60","author":"J Pan","year":"2016","unstructured":"Pan J, Lee Y, Wang Y, You M (2016) Honokiol targets mitochondria to halt cancer progression and metastasis. Mol Nutr Food Res 60(6):1383\u20131395. https:\/\/doi.org\/10.1002\/mnfr.201501007","journal-title":"Mol Nutr Food Res"},{"issue":"5","key":"2346_CR173","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3892\/ijo.2017.4145","volume":"51","author":"H Pan","year":"2017","unstructured":"Pan H, Wang F, Rankin GO, Rojanasakul Y, Tu Y, Chen Y (2017) Inhibitory effect of black tea pigments, theaflavin-3\/3\u2032-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest. Int J Oncol 51(5):1508\u20131520. https:\/\/doi.org\/10.3892\/ijo.2017.4145","journal-title":"Int J Oncol"},{"issue":"1","key":"2346_CR144","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/cancers12010213","volume":"12","author":"M Pantshwa","year":"2020","unstructured":"Pantshwa M, Kondiah JPD, Choonara PE, Marimuthu Y, T., Pillay V (2020) Nanodrug delivery systems for the treatment of ovarian cancer. Cancers 12(1):213\u2013213. https:\/\/doi.org\/10.3390\/cancers12010213","journal-title":"Cancers"},{"issue":"1","key":"2346_CR175","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"Peng D, Fu M, Wang M, Wei Y, Wei X (2022) Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy. Mol Cancer 21(1):104\u2013104. https:\/\/doi.org\/10.1186\/s12943-022-01569-x","journal-title":"Mol Cancer"},{"key":"2346_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10335-5","author":"B Pereira","year":"2019","unstructured":"Pereira B, Devine O, Vukmanovic-Stejic M, Chambers ES, Subramanian P, Patel N, Virasami A, Sebire NJ, Kinsler VA, Valdovinos A, Saux CJL, Passos JF, Antoniou AN, Rustin MHA, Campisi J, Akbar AN (2019) Senescent cells evade immune clearance via HLA-E-mediated NK and CD8\u2009+\u2009T cell inhibition. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-10335-5","journal-title":"Nat Commun"},{"issue":"7","key":"2346_CR177","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1021\/acsptsci.5c00253","volume":"8","author":"MB Pinto","year":"2025","unstructured":"Pinto MB, Pires PC, Correia M, Mo\u00e7o G, Sousa-Oliveira I, Sousa MJ, Calhelha RC, Vilas\u2010Boas M, Falc\u00e3o SI, Mazzola PG, Veiga F, Paiva\u2010Santos AC (2025) Propolis-loaded niosomes for dermopharmaceutic and cosmetic applications: development, stability, safety, and in vitro bioactivity studies. ACS Pharmacol Translational Sci 8(7):2220\u20132246. https:\/\/doi.org\/10.1021\/acsptsci.5c00253","journal-title":"ACS Pharmacol Translational Sci"},{"key":"2346_CR178","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1343523","author":"O Piw\u00f3cka","year":"2024","unstructured":"Piw\u00f3cka O, Piotrowski I, Suchorska WM, Kulcenty K (2024) Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2024.1343523","journal-title":"Front Mol Biosci"},{"key":"2346_CR179","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-020-00731-7","author":"MH Pourhanifeh","year":"2020","unstructured":"Pourhanifeh MH, Darvish M, Tabatabaeian J, Fard MR, Mottaghi R, Azadchehr MJ, Jahanshahi M, Sahebkar A, Mirzaei H (2020) Therapeutic role of curcumin and its novel formulations in gynecological cancers. J Ovarian Res. https:\/\/doi.org\/10.1186\/s13048-020-00731-7","journal-title":"J Ovarian Res"},{"key":"2346_CR180","doi-asserted-by":"publisher","first-page":"101275","DOI":"10.1016\/j.smim.2019.04.003","volume":"40","author":"L Prata","year":"2018","unstructured":"Prata L, Ovsyannikova IG, Tchkonia T, Kirkland JL (2018) Senescent cell clearance by the immune system: Emerging therapeutic opportunities. Semin Immunol 40:101275\u2013101275. https:\/\/doi.org\/10.1016\/j.smim.2019.04.003","journal-title":"Semin Immunol"},{"key":"2346_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00313-5","author":"S Qin","year":"2020","unstructured":"Qin S, Jiang J, L\u00fc Y, Nice EC, Huang C, Zhang J, He W (2020) Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-020-00313-5","journal-title":"Signal Transduct Target Therapy"},{"issue":"19","key":"2346_CR182","doi-asserted-by":"publisher","first-page":"21954","DOI":"10.1021\/acsami.2c02552","volume":"14","author":"M Qiu","year":"2022","unstructured":"Qiu M, Chen J, Huang X, Li B, Zhang S, Liu P, Wang Q, Qian ZR, Pan Y, Chen Y, Zhao J (2022) Engineering chemotherapeutic-augmented calcium phosphate nanoparticles for treatment of intraperitoneal disseminated ovarian cancer. ACS Appl Mater Interfaces 14(19):21954\u201321965. https:\/\/doi.org\/10.1021\/acsami.2c02552","journal-title":"ACS Appl Mater Interfaces"},{"key":"2346_CR183","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01370","author":"S Quintero-Fabi\u00e1n","year":"2019","unstructured":"Quintero-Fabi\u00e1n S, Arreola R, Becerril-Villanueva E, Torres\u2010Romero JC, Arana\u2010Arg\u00e1ez VE, Lara\u2010Riegos J, Ram\u00edrez-Camacho MA, \u00c1lvarez-S\u00e1nchez ME (2019) Role of matrix metalloproteinases in angiogenesis and cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.01370","journal-title":"Frontiers Oncology 9 Front Media"},{"key":"2346_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/s2666-7568(21)00300-7","author":"M Raffaele","year":"2022","unstructured":"Raffaele M, Vinciguerra M (2022) The costs and benefits of senotherapeutics for human health. Lancet Healthy Longev. https:\/\/doi.org\/10.1016\/s2666-7568(21)00300-7","journal-title":"Lancet Healthy Longev"},{"key":"2346_CR185","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-020-00213-w","author":"E Ragonnaud","year":"2021","unstructured":"Ragonnaud E, Biragyn A (2021) Gut microbiota as the key controllers of healthy aging of elderly people. Immun Ageing. https:\/\/doi.org\/10.1186\/s12979-020-00213-w","journal-title":"Immun Ageing"},{"key":"2346_CR186","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70257","author":"NP Rees","year":"2025","unstructured":"Rees NP, Conway J, Dugan B, Amir S, Parker A, Carding SR, Duggal NA (2025) Defining microbiota-derived metabolite butyrate as a senomorphic: therapeutic potential in the age\u2010related T cell senescence. Aging Cell. https:\/\/doi.org\/10.1111\/acel.70257","journal-title":"Aging Cell"},{"key":"2346_CR187","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232136","author":"M Reimann","year":"2024","unstructured":"Reimann M, Lee S, Schmitt CA (2024) Cellular senescence: neither irreversible nor reversible. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20232136","journal-title":"J Exp Med"},{"issue":"2","key":"2346_CR188","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1101\/gad.290635.116","volume":"31","author":"B Ritschka","year":"2017","unstructured":"Ritschka B, Storer MA, Mas A, Heinzmann F, Ortells MC, Morton JP, Sansom OJ, Zender L, Keyes WM (2017) The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev 31(2):172\u2013183. https:\/\/doi.org\/10.1101\/gad.290635.116","journal-title":"Genes Dev"},{"issue":"1","key":"2346_CR189","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1146\/annurev-pharmtox-050120-105018","volume":"61","author":"PD Robbins","year":"2020","unstructured":"Robbins PD, Jurk D, Khosla S, Kirkland JL, LeBrasseur NK, Miller JD, Passos JF, Pignolo RJ, Tchkonia T, Niedernhofer LJ (2020) Senolytic drugs: reducing senescent cell viability to extend health span. Annual Rev Pharmacol Toxicol 61(1):779\u2013803. https:\/\/doi.org\/10.1146\/annurev-pharmtox-050120-105018","journal-title":"Annual Rev Pharmacol Toxicol"},{"key":"2346_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11762","author":"MK Ruhland","year":"2016","unstructured":"Ruhland MK, Loza AJ, Capietto A-H, Luo X, Knolhoff BL, Flanagan KC, Belt BA, Alspach E, Leahy K, Luo J, Schaffer A, Edwards JR, Longmore GD, Faccio R, DeNardo DG, Stewart SA (2016) Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat Commun. https:\/\/doi.org\/10.1038\/ncomms11762","journal-title":"Nat Commun"},{"issue":"11","key":"2346_CR191","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc3803","volume":"14","author":"SS Sabharwal","year":"2014","unstructured":"Sabharwal SS, Schumacker PT (2014) Mitochondrial ROS in cancer: Initiators, amplifiers or an Achilles\u2019 heel? Nat Rev Cancer 14(11):709\u2013721. https:\/\/doi.org\/10.1038\/nrc3803","journal-title":"Nat Rev Cancer"},{"key":"2346_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00164","author":"T Saleh","year":"2018","unstructured":"Saleh T, Tyutynuk-Massey L, Cudjoe EK, Idowu MO, Landry JW, Gewirtz DA (2018) Non-cell autonomous effects of the senescence-associated secretory phenotype in cancer therapy. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2018.00164","journal-title":"Frontiers Oncology 8 Front Media"},{"issue":"1","key":"2346_CR193","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.foodchem.2011.08.011","volume":"131","author":"F S\u00e1nchez-Pat\u00e1n","year":"2011","unstructured":"S\u00e1nchez-Pat\u00e1n F, Cueva C, Monagas M, Walton G, Gibson GR, Mart\u00edn\u2010\u00c1lvarez PJ, Moreno\u2010Arribas MV, Bartolom\u00e9 B (2011) Gut microbial catabolism of grape seed flavan-3-ols by human faecal microbiota. Targetted analysis of precursor compounds, intermediate metabolites and end-products. Food Chem 131(1):337\u2013347. https:\/\/doi.org\/10.1016\/j.foodchem.2011.08.011","journal-title":"Food Chem"},{"key":"2346_CR194","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.603235","author":"NMD Sandhiutami","year":"2021","unstructured":"Sandhiutami NMD, Arozal W, Louisa M, Rahmat D, Wuyung PE (2021) Curcumin nanoparticle enhances the anticancer effect of cisplatin by inhibiting PI3K\/AKT and JAK\/STAT3 pathway in rat ovarian carcinoma induced by DMBA. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.603235","journal-title":"Front Pharmacol"},{"issue":"8","key":"2346_CR195","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3390\/ph18081176","volume":"18","author":"JA Santiago-de-la-Cruz","year":"2025","unstructured":"Santiago-de-la-Cruz JA, Rivero-Segura NA, \u00c1lvarez-S\u00e1nchez ME, G\u00f3mez-Verj\u00e1n JC (2025) Network pharmacology and machine learning identify flavonoids as potential senotherapeutics. Pharmaceuticals 18(8):1176\u20131176. https:\/\/doi.org\/10.3390\/ph18081176","journal-title":"Pharmaceuticals"},{"key":"2346_CR196","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00278","author":"M Schosserer","year":"2017","unstructured":"Schosserer M, Grillari J, Breitenbach M (2017) The dual role of cellular senescence in developing tumors and their response to cancer therapy. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2017.00278","journal-title":"Frontiers Oncology 7 Front Media"},{"issue":"3","key":"2346_CR197","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s11357-020-00274-1","volume":"43","author":"R Selvarani","year":"2020","unstructured":"Selvarani R, Mohammed S, Richardson A (2020) Effect of rapamycin on aging and age-related diseases\u2014past and future. GeroScience 43(3):1135\u20131158. https:\/\/doi.org\/10.1007\/s11357-020-00274-1","journal-title":"GeroScience"},{"key":"2346_CR198","doi-asserted-by":"publisher","DOI":"10.1172\/jci158452","author":"S Shafqat","year":"2022","unstructured":"Shafqat S, Chicas EA, Shafqat A, Hashmi SK (2022) The Achilles\u2019 heel of cancer survivors: fundamentals of accelerated cellular senescence. J Clin Invest. https:\/\/doi.org\/10.1172\/jci158452","journal-title":"J Clin Invest"},{"issue":"2","key":"2346_CR199","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/molecules20022728","volume":"20","author":"MK Shanmugam","year":"2015","unstructured":"Shanmugam MK, Rane G, Kanchi MM, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Tan BKH, Kumar AP, Sethi G (2015) The multifaceted role of curcumin in cancer prevention and treatment. Molecules 20(2):2728\u20132769. https:\/\/doi.org\/10.3390\/molecules20022728","journal-title":"Molecules"},{"issue":"1","key":"2346_CR200","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/molecules25010228","volume":"25","author":"HJ Shin","year":"2020","unstructured":"Shin HJ, Han JM, Choi YS, Jung HJ (2020) Pterostilbene suppresses both cancer cells and cancer stem-like cells in cervical cancer with superior bioavailability to resveratrol. Molecules 25(1):228\u2013228. https:\/\/doi.org\/10.3390\/molecules25010228","journal-title":"Molecules"},{"issue":"9","key":"2346_CR201","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.tcb.2018.04.006","volume":"28","author":"CJ Sieben","year":"2018","unstructured":"Sieben CJ, Sturmlechner I, van de Sluis B, van Deursen JM (2018) Two-step senescence-focused cancer therapies. Trends Cell Biol 28(9):723\u2013737. https:\/\/doi.org\/10.1016\/j.tcb.2018.04.006","journal-title":"Trends Cell Biol"},{"issue":"23","key":"2346_CR203","doi-asserted-by":"publisher","first-page":"10286","DOI":"10.1039\/d3fo03065b","volume":"14","author":"PM Silva","year":"2023","unstructured":"Silva PM, Gon\u00e7alves C, Pastrana L, Coimbra MA, Vicente AA, Cerqueira MA (2023) Recent advances in oral delivery systems of resveratrol: foreseeing their use in functional foods. Food Funct 14(23):10286\u201310313. https:\/\/doi.org\/10.1039\/d3fo03065b","journal-title":"Food Funct"},{"key":"2346_CR202","doi-asserted-by":"publisher","first-page":"105175","DOI":"10.1016\/j.critrevonc.2026.105175","volume":"220","author":"I Silva","year":"2026","unstructured":"Silva I, Khalil N, Fan CLF, Wang YE, Leveridge B, Miceli GC, Lee A, Goding J, Green RA, Boshier PR (2026) Hydrogel-based drug delivery systems for localised treatment of peritoneal metastasis: a systematic and ideal framework review. Crit Rev Oncol\/Hematol 220:105175\u2013105175. https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105175","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"2346_CR204","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39120-1","author":"V Smer-Barreto","year":"2023","unstructured":"Smer-Barreto V, Quintanilla A, Elliott R, Dawson JC, Sun J, Campa VM, Lorente-Mac\u00edas \u00c1, Unciti\u2010Broceta A, Carragher NO, Acosta JC, Oyarz\u00fan DA (2023) Discovery of senolytics using machine learning. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-023-39120-1","journal-title":"Nat Commun"},{"issue":"4","key":"2346_CR205","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3892\/ijo.2015.3122","volume":"47","author":"KA So","year":"2015","unstructured":"So KA, Min K, Hong JH, Lee JK (2015) Interleukin-6 expression by interactions between gynecologic cancer cells and human mesenchymal stem cells promotes epithelial-mesenchymal transition. Int J Oncol 47(4):1451\u20131459. https:\/\/doi.org\/10.3892\/ijo.2015.3122","journal-title":"Int J Oncol"},{"key":"2346_CR206","doi-asserted-by":"publisher","first-page":"112033","DOI":"10.1016\/j.cbi.2026.112033","volume":"432","author":"K Solarska-\u015aciuk","year":"2026","unstructured":"Solarska-\u015aciuk K, Kapavarapu R, Poliszak Z, Wnuk M, Lewi\u0144ska A (2026) Sulforaphane promotes the removal of doxorubicin-induced senescent epithelial and breast cancer cells and activates AhR\/CYP1A1-based adaptive response in vitro. Chemico-Biol Interact 432:112033\u2013112033. https:\/\/doi.org\/10.1016\/j.cbi.2026.112033","journal-title":"Chemico-Biol Interact"},{"issue":"5","key":"2346_CR207","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.advnut.2023.05.014","volume":"14","author":"V Sorrenti","year":"2023","unstructured":"Sorrenti V, Buriani A, Fortinguerra S, Davinelli S, Scapagnini G, Cassidy A, Vivo ID (2023) Cell survival, death, and proliferation in senescent and cancer cells: the role of (Poly)phenols. PubMed Cent 14(5):1111\u20131130. https:\/\/doi.org\/10.1016\/j.advnut.2023.05.014","journal-title":"PubMed Cent"},{"issue":"7","key":"2346_CR208","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3390\/biomedicines10071686","volume":"10","author":"J Stabrauskien\u0117","year":"2022","unstructured":"Stabrauskien\u0117 J, Kopustinskien\u0117 DM, La\u017eauskas R, Bernatonien\u0117 J (2022) Naringin and naringenin: their mechanisms of action and the potential anticancer activities. Biomedicines 10(7):1686\u20131686. https:\/\/doi.org\/10.3390\/biomedicines10071686","journal-title":"Biomedicines"},{"key":"2346_CR209","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0586-1","author":"AR Straughn","year":"2019","unstructured":"Straughn AR, Kakar SS (2019) Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signalling. J Ovarian Res. https:\/\/doi.org\/10.1186\/s13048-019-0586-1","journal-title":"J Ovarian Res"},{"key":"2346_CR210","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01153","author":"L Sun","year":"2019","unstructured":"Sun L, Zhou W, Zhang H, Guo Q, Yang W, Li B, Sun Z, Gao S, Cui R (2019) Modulation of multiple signalling pathways of the plant-derived natural products in cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.01153","journal-title":"Frontiers Oncology 9 Front Media"},{"key":"2346_CR211","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00815-5","author":"Y Sun","year":"2022","unstructured":"Sun Y, Wang X, Liu T, Zhu X, Pan X (2022) The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities. Cell Biosc. https:\/\/doi.org\/10.1186\/s13578-022-00815-5","journal-title":"Cell Bioscience"},{"issue":"6","key":"2346_CR212","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.21037\/apm-24-90","volume":"13","author":"W Sung","year":"2024","unstructured":"Sung W, Sharma K, Chan AW, Khaifi MA, Oldenburger E, Chuk E (2024) A narrative review of the challenges and impact of breast cancer treatment in older adults beyond cancer diagnosis. Lirias (KU Leuven) 13(6):1521\u20131529. https:\/\/doi.org\/10.21037\/apm-24-90","journal-title":"Lirias (KU Leuven)"},{"issue":"2","key":"2346_CR213","doi-asserted-by":"publisher","first-page":"100147","DOI":"10.1016\/j.tjfa.2026.100147","volume":"15","author":"L Tagliafico","year":"2026","unstructured":"Tagliafico L, Canevelli M, Barreto PDS, Cesari M, Ferrucci L, Vellas B, Rolland Y (2026) Insights on geroscience pre-clinical and clinical trials to promote healthy aging from the Intrinsic Capacity, Frailty and Sarcopenia Research Task Force 2025. J Frailty Aging 15(2):100147\u2013100147. https:\/\/doi.org\/10.1016\/j.tjfa.2026.100147","journal-title":"J Frailty Aging"},{"issue":"3","key":"2346_CR214","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1172\/jci64098","volume":"123","author":"T Tchkonia","year":"2013","unstructured":"Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL (2013) Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 123(3):966\u2013972. https:\/\/doi.org\/10.1172\/jci64098","journal-title":"J Clin Invest"},{"key":"2346_CR215","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00319","author":"N Terraneo","year":"2020","unstructured":"Terraneo N, Jacob F, Dubrovska A, Gr\u00fcnberg J (2020) Novel therapeutic strategies for ovarian cancer stem cells. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.00319","journal-title":"Front Oncol"},{"key":"2346_CR216","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05017-x","author":"BV Thapa","year":"2023","unstructured":"Thapa BV, Banerjee M, Glimm T, Saini DK, Bhat R (2023) The senescent mesothelial matrix accentuates colonization by ovarian cancer cells. Cell Mol Life Sci. https:\/\/doi.org\/10.1007\/s00018-023-05017-x","journal-title":"Cell Mol Life Sci"},{"key":"2346_CR217","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01282-8","author":"Y Tie","year":"2022","unstructured":"Tie Y, Tang F, Wei Y, Wei X (2022) Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-022-01282-8","journal-title":"J Hematol Oncol"},{"key":"2346_CR218","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20190452","author":"J Tong","year":"2019","unstructured":"Tong J, Shen Y, Zhang Z, Hu Y, Zhang X, Han L (2019) Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-\u03baB\/Snail signalling pathway. Biosci Rep. https:\/\/doi.org\/10.1042\/bsr20190452","journal-title":"Biosci Rep"},{"key":"2346_CR219","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00956-5","author":"W Topatana","year":"2020","unstructured":"Topatana W, Juengpanich S, Li S, Cao J, Hu J, Lee J, Suliyanto K, Ma D, Zhang B, Chen M, Cai X (2020) Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-020-00956-5","journal-title":"J Hematol Oncol"},{"issue":"12","key":"2346_CR220","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.21873\/anticanres.11234","volume":"36","author":"P-H Tsai","year":"2016","unstructured":"Tsai P-H, Cheng C, Lin C, Huang Y-T, Lee L-T, Kandaswami C, Lin Y-C, Hung LEEKP-H, Hwang C, Ke J-J, Chang F, G.-D., Lee M-T (2016) Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells. Anticancer Res 36(12):6367\u20136380. https:\/\/doi.org\/10.21873\/anticanres.11234","journal-title":"Anticancer Res"},{"issue":"6","key":"2346_CR221","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.3892\/ijo.2016.3472","volume":"48","author":"Y Tu","year":"2016","unstructured":"Tu Y, Kim E, Gao Y, Rankin GO, Li B, Chen Y (2016) Theaflavin-3, 3\u2032-digallate induces apoptosis and G2 cell cycle arrest through the Akt\/MDM2\/p53 pathway in cisplatin-resistant ovarian cancer A2780\/CP70 cells. Int J Oncol 48(6):2657\u20132665. https:\/\/doi.org\/10.3892\/ijo.2016.3472","journal-title":"Int J Oncol"},{"key":"2346_CR222","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-020-00397-0","author":"A Vafadar","year":"2020","unstructured":"Vafadar A, Shabaninejad Z, Movahedpour A, Fallahi F, Taghavipour M, Ghasemi Y, Akbari M, Shafiee A, Hajighadimi S, Moradizarmehri S, Razi E, Savardashtaki A, Mirzaei H (2020) Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells. Cell Biosci. https:\/\/doi.org\/10.1186\/s13578-020-00397-0","journal-title":"Cell Bioscience"},{"issue":"6","key":"2346_CR223","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1007\/s10311-021-01276-x","volume":"19","author":"G Vanti","year":"2021","unstructured":"Vanti G (2021) Recent strategies in nanodelivery systems for natural products: a review. Environ Chem Lett 19(6):4311\u20134326. https:\/\/doi.org\/10.1007\/s10311-021-01276-x","journal-title":"Environ Chem Lett"},{"key":"2346_CR224","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-020-02900-z","author":"L Varela-Rodr\u00edguez","year":"2020","unstructured":"Varela-Rodr\u00edguez L, S\u00e1nchez-Ram\u00edrez B, Hern\u00e1ndez-Ram\u0131\u0301rez VI, Varela-Rodr\u00edguez H, Castellanos-Mijangos RD, Gonz\u00e1lez\u2010Horta C, Ch\u00e1vez\u2010Mungu\u00eda B, Talam\u00e1s\u2010Rohana P (2020) Effect of gallic acid and myricetin on ovarian cancer models: a possible alternative antitumoral treatment. BMC Complement Med Ther. https:\/\/doi.org\/10.1186\/s12906-020-02900-z","journal-title":"BMC Complement Med Ther"},{"issue":"10","key":"2346_CR225","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1021\/acsabm.5c00777","volume":"8","author":"A Vashist","year":"2025","unstructured":"Vashist A, Manickam P, Karuppaiah G, \u00c1lvarez G, Camargo VA, Bhunia S, Kolishetti N, Raymond A, Yndart A, Vashist A, Atluri V, Runowicz CD, Nair M (2025) Recent advances in diagnostic strategies and nanotechnology-based therapies for ovarian cancer treatment. ACS Appl Bio Mater 8(10):8421\u20138448. https:\/\/doi.org\/10.1021\/acsabm.5c00777","journal-title":"ACS Appl Bio Mater"},{"issue":"2","key":"2346_CR226","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/ph18020138","volume":"18","author":"LD Vedova","year":"2025","unstructured":"Vedova LD, Baron G, Morazzoni P, Aldini G, Gado F (2025) The potential of polyphenols in modulating the cellular senescence process: implications and mechanism of action. Pharmaceuticals 18(2):138\u2013138. https:\/\/doi.org\/10.3390\/ph18020138","journal-title":"Pharmaceuticals"},{"key":"2346_CR228","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01280","author":"L Walcher","year":"2020","unstructured":"Walcher L, Kistenmacher A-K, Suo H, Kitte R, Dluczek S, Strau\u00df A, Blaudszun A, Yevsa T, Fricke S, Kossatz-Boehlert U (2020) Cancer stem cells\u2014origins and biomarkers: perspectives for targeted personalized therapies. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.01280","journal-title":"Frontiers Immunology 11 Front Media"},{"issue":"3","key":"2346_CR229","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/biom14030288","volume":"14","author":"D Wang","year":"2024","unstructured":"Wang D, Liu L (2024) Senescence promotes the recovery of stemness among cancer cells via reprograming. Biomolecules 14(3):288\u2013288. https:\/\/doi.org\/10.3390\/biom14030288","journal-title":"Biomolecules"},{"issue":"11","key":"2346_CR233","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.18632\/aging.101100","volume":"8","author":"Y Wang","year":"2016","unstructured":"Wang Y, Chang J, Liu X, Zhang X, Zhang S, Zhang X, Zhou D, Zheng G (2016) Discovery of piperlongumine as a potential novel lead for the development of senolytic agents. Aging 8(11):2915\u20132926. https:\/\/doi.org\/10.18632\/aging.101100","journal-title":"Aging"},{"key":"2346_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0223-0","author":"Z Wang","year":"2018","unstructured":"Wang Z, Ma L, Su M, Zhou Y, Mao K, Li C, Peng G, Zhou C, Shen B, Dou J (2018) Baicalin induces cellular senescence in human colon cancer cells via upregulation of DEPP and the activation of Ras\/Raf\/MEK\/ERK signalling. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-017-0223-0","journal-title":"Cell Death Dis"},{"issue":"23","key":"2346_CR231","doi-asserted-by":"publisher","first-page":"14473","DOI":"10.18632\/aging.205269","volume":"15","author":"L Wang","year":"2023","unstructured":"Wang L, Wang J, Yang Z, Wang Y, Zhao T, Luo W, Liang T, Zheng Y (2023) Traditional herbs: mechanisms to combat cellular senescence. Aging 15(23):14473\u201314505. https:\/\/doi.org\/10.18632\/aging.205269","journal-title":"Aging"},{"key":"2346_CR232","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01967-3","author":"L Wang","year":"2024","unstructured":"Wang L, Wang X, Zhu X, Zhong L, Jiang Q, Wang Y, Tang Q, Li Q, Zhang C, Wang H, Zou D (2024a) Drug resistance in ovarian cancer: from mechanism to clinical trial. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-024-01967-3","journal-title":"Mol Cancer"},{"issue":"1","key":"2346_CR235","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/imm.13793","volume":"173","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhang X, Fang C, Liu X, Liao Q, Wu N, Wang J (2024b) Immunotherapy and the ovarian cancer microenvironment: exploring potential strategies for enhanced treatment efficacy. Immunology 173(1):14\u201332. https:\/\/doi.org\/10.1111\/imm.13793","journal-title":"Immunology"},{"issue":"9","key":"2346_CR230","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1016\/j.apsb.2025.07.022","volume":"15","author":"H Wang","year":"2025","unstructured":"Wang H, Yu Y, Li R, Zhang H, Chen Z, Sun C, Zhuang J (2025) Immunoregulatory mechanisms in the aging microenvironment: targeting the senescence-associated secretory phenotype for cancer immunotherapy. Acta Pharm Sinica B 15(9):4476\u20134496. https:\/\/doi.org\/10.1016\/j.apsb.2025.07.022","journal-title":"Acta Pharm Sinica B"},{"key":"2346_CR236","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01288-1","author":"X Wei","year":"2021","unstructured":"Wei X, Chen Y, Jiang X, Miao P, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Xiong W, Zeng Z (2021) Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-020-01288-1","journal-title":"Mol Cancer"},{"issue":"2","key":"2346_CR237","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000484629","volume":"64","author":"T Weichhart","year":"2017","unstructured":"Weichhart T (2017) mTOR as regulator of lifespan, aging, and cellular senescence: a mini-review. Gerontology 64(2):127\u2013134. https:\/\/doi.org\/10.1159\/000484629","journal-title":"Gerontology"},{"issue":"7","key":"2346_CR238","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.3390\/ijms19071983","volume":"19","author":"W Wen","year":"2018","unstructured":"Wen W, Lowe G, Roberts CM, Finlay J, Han E, Glackin CA, Dellinger TH (2018) Pterostilbene suppresses ovarian cancer growth via induction of apoptosis and blockade of cell cycle progression involving inhibition of the STAT3 pathway. Int J Mol Sci 19(7):1983\u20131983. https:\/\/doi.org\/10.3390\/ijms19071983","journal-title":"Int J Mol Sci"},{"key":"2346_CR239","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00024","author":"T Worzfeld","year":"2017","unstructured":"Worzfeld T, von Strandmann EP, Huber M, Adhikary T, Wagner U, Reinartz S, M\u00fcller R (2017) The unique molecular and cellular microenvironment of ovarian cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2017.00024","journal-title":"Frontiers Oncology 7 Front Media"},{"issue":"1","key":"2346_CR240","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","volume":"21","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yi M, Niu M, Mei Q, Wu K (2022) Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy. Mol Cancer 21(1):184\u2013184. https:\/\/doi.org\/10.1186\/s12943-022-01657-y. BioMed Central","journal-title":"Mol Cancer"},{"issue":"8","key":"2346_CR241","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3390\/cancers12082134","volume":"12","author":"L Wyld","year":"2020","unstructured":"Wyld L, Bellantuono I, Tchkonia T, Morgan J, Turner O, Foss F, George J, Danson S, Kirkland JL (2020) Senescence and cancer: a review of clinical implications of senescence and senotherapies. Cancers 12(8):2134\u20132134. https:\/\/doi.org\/10.3390\/cancers12082134","journal-title":"Cancers"},{"key":"2346_CR242","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01808-1","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin W (2024) Drug repurposing for cancer therapy. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-024-01808-1","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR243","doi-asserted-by":"publisher","first-page":"1189015","DOI":"10.3389\/fonc.2023.1189015","volume":"13","author":"S Xiao","year":"2023","unstructured":"Xiao S, Qin D, Hou X, Tian L, Yu Y, Zhang R, Lyu H, Guo D, Chen X, Zhou C, Tang J (2023) Cellular senescence: a double-edged sword in cancer therapy. Front Oncol 13:1189015\u20131189015. https:\/\/doi.org\/10.3389\/fonc.2023.1189015","journal-title":"Front Oncol"},{"key":"2346_CR244","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02136-y","author":"W Xie","year":"2021","unstructured":"Xie W, Sun H, Li X, Lin F, Wang Z, Wang X (2021) Ovarian cancer: epigenetics, drug resistance, and progression. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-021-02136-y","journal-title":"Cancer Cell Int"},{"key":"2346_CR245","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1265525","author":"J Xiong","year":"2023","unstructured":"Xiong J, Fu Y, Huang J, Wang Y, Jin X, Xiao-yan W, Huang L, Huang Z (2023) Metabolic and senescence characteristics associated with the immune microenvironment in ovarian cancer. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2023.1265525","journal-title":"Frontiers Endocrinology 14 Front Media"},{"issue":"6","key":"2346_CR250","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tibs.2014.04.004","volume":"39","author":"Y Xu","year":"2014","unstructured":"Xu Y, Li N, Xiang R, Sun P (2014) Emerging roles of the p38 MAPK and PI3K\/AKT\/mTOR pathways in oncogene-induced senescence. Trends Biochem Sci 39(6):268\u2013276. https:\/\/doi.org\/10.1016\/j.tibs.2014.04.004","journal-title":"Trends Biochem Sci"},{"key":"2346_CR246","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.phrs.2016.05.015","volume":"111","author":"M Xu","year":"2016","unstructured":"Xu M, Tchkonia T, Kirkland JL (2016) Perspective: targeting the JAK\/STAT pathway to fight age-related dysfunction. Pharmacol Res 111:152\u2013154. https:\/\/doi.org\/10.1016\/j.phrs.2016.05.015","journal-title":"Pharmacol Res"},{"key":"2346_CR247","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-421222\/v1","author":"Q Xu","year":"2021","unstructured":"Xu Q, Fu Q, Li Z, Liu H, Wang Y, Lin X, He R, Zhang X, Campisi J, Kirkland JL, Sun Y (2021a) Procyanidin C1 is a natural agent with senolytic activity against aging and age-related diseases. Res Square (Research Square). https:\/\/doi.org\/10.21203\/rs.3.rs-421222\/v1","journal-title":"Res Square (Research Square)"},{"issue":"12","key":"2346_CR248","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s42255-021-00491-8","volume":"3","author":"Q Xu","year":"2021","unstructured":"Xu Q, Fu Q, Li Z, Liu H, Wang Y, Lin X, He R, Zhang X, Ju Z, Campisi J, Kirkland JL, Sun Y (2021b) The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice. Nat Metabolism 3(12):1706\u20131726. https:\/\/doi.org\/10.1038\/s42255-021-00491-8","journal-title":"Nat Metabolism"},{"issue":"11","key":"2346_CR249","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3390\/antiox10111718","volume":"10","author":"X-L Xu","year":"2021","unstructured":"Xu X-L, Deng S, Lian Z, Yu K (2021c) Resveratrol targets a variety of oncogenic and oncosuppressive signalling for ovarian cancer prevention and treatment. Antioxidants 10(11):1718\u20131718. https:\/\/doi.org\/10.3390\/antiox10111718","journal-title":"Antioxidants"},{"issue":"1","key":"2346_CR251","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ijc.25961","volume":"130","author":"S Yamamura","year":"2011","unstructured":"Yamamura S, Matsumura N, Mandai M, Huang Z, Oura T, Baba T, Hamanishi J, Yamaguchi K, Kang H, Okamoto T, Abiko K, Mori S, Murphy SK, Konishi I (2011) The activated transforming growth factor-beta signalling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer. Int J Cancer 130(1):20\u201328. https:\/\/doi.org\/10.1002\/ijc.25961","journal-title":"Int J Cancer"},{"issue":"5","key":"2346_CR252","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2020.12001","volume":"20","author":"Y-B Yan","year":"2020","unstructured":"Yan Y-B, Tian Q, Zhang J, Xiang Y (2020) Antitumor effects and molecular mechanisms of action of natural products in ovarian cancer (Review). Oncol Lett 20(5):1\u20131. https:\/\/doi.org\/10.3892\/ol.2020.12001","journal-title":"Oncol Lett"},{"key":"2346_CR254","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0804-8","author":"L Yang","year":"2019","unstructured":"Yang L, Li A, Lei Q, Zhang Y (2019) Tumor-intrinsic signalling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-019-0804-8","journal-title":"J Hematol Oncol"},{"key":"2346_CR255","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0110-5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, Zhang G, Wang X, Dong Z, Chen F, Cui H (2020a) Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-020-0110-5","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR258","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00758","author":"Y Yang","year":"2020","unstructured":"Yang Y, Yang Y, Yang J, Zhao X, Wei X (2020b) Tumor microenvironment in ovarian cancer: function and therapeutic strategy. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2020.00758","journal-title":"Frontiers Cell Dev Biology 8 Front Media"},{"key":"2346_CR253","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1043056","author":"H Yang","year":"2022","unstructured":"Yang H, Xu S, Tang L, Gong J, Fang H, Wei J, Su D (2022) Targeting of non-apoptotic cancer cell death mechanisms by quercetin: implications in cancer therapy. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1043056","journal-title":"Frontiers Pharmacology 13 Front Media"},{"key":"2346_CR257","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207366","author":"Q Yang","year":"2023","unstructured":"Yang Q, Wang B, Zheng Q, Li H, Meng X, Zhou F, Zhang L (2023) A review of gut microbiota-derived metabolites in tumor progression and cancer therapy. PubMed Cent. https:\/\/doi.org\/10.1002\/advs.202207366","journal-title":"PubMed Cent"},{"issue":"7","key":"2346_CR256","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1021\/acs.jafc.4c09205","volume":"73","author":"M Yang","year":"2025","unstructured":"Yang M, Zhang X, Yang CS (2025) Bioavailability of tea polyphenols: a key factor in understanding their mechanisms of action in vivo and health effects. J Agric Food Chem 73(7):3816\u20133825. https:\/\/doi.org\/10.1021\/acs.jafc.4c09205","journal-title":"J Agric Food Chem"},{"key":"2346_CR259","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01868-3","author":"M Yi","year":"2024","unstructured":"Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, Dai Z (2024) Targeting cytokine and chemokine signalling pathways for cancer therapy. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-024-01868-3","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"2346_CR260","doi-asserted-by":"publisher","first-page":"11190","DOI":"10.1038\/ncomms11190","volume":"7","author":"R Yosef","year":"2016","unstructured":"Yosef R, Pilpel N, Tokarsky-Amiel R, Biran A, Ovadya Y, Cohen S, Vadai E, Dassa L, Shahar E, Condiotti R, Ben-Porath I, Krizhanovsky V (2016) Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun 7(1):11190\u201311190. https:\/\/doi.org\/10.1038\/ncomms11190","journal-title":"Nat Commun"},{"key":"2346_CR261","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","volume":"36","author":"MJ Yousefzadeh","year":"2018","unstructured":"Yousefzadeh MJ, Zhu Y, McGowan SJ, Angelini L, Fuhrmann-Stroissnigg H, Xu M, Ling YY, Melos KI, Pirtskhalava T, Inman CL, McGuckian CA, Wade EA, Kato JI, Grassi D, Wentworth M, Burd CE, Arriaga EA, Ladiges W, Tchkonia T, Niedernhofer LJ (2018) Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine 36:18\u201328. https:\/\/doi.org\/10.1016\/j.ebiom.2018.09.015","journal-title":"EBioMedicine"},{"key":"2346_CR262","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02804-7","author":"S Zafar","year":"2022","unstructured":"Zafar S, Khan K, Hafeez A, Irfan M, Armaghan M, Rahman A, G\u00fcrer ES, Sharifi-Rad J, Butnariu M, Bagiu IC, Bagiu RV (2022) Ursolic acid: a natural modulator of signalling networks in different cancers. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-022-02804-7","journal-title":"Cancer Cell Int"},{"issue":"9","key":"2346_CR263","doi-asserted-by":"publisher","first-page":"10875","DOI":"10.1021\/acsomega.3c09782","volume":"9","author":"MK Zenjanab","year":"2024","unstructured":"Zenjanab MK, Abdolahinia ED, Alizadeh E, Hamishehkar H, Shahbazi R, Ranjbar-Navazi Z, Jahanban-Esfahlan R, Fathi M, Mohammadi SA (2024) Hyaluronic acid-targeted niosomes for effective breast cancer chemostarvation therapy. ACS Omega 9(9):10875\u201310885. https:\/\/doi.org\/10.1021\/acsomega.3c09782","journal-title":"ACS Omega"},{"issue":"30","key":"2346_CR264","doi-asserted-by":"publisher","first-page":"25174","DOI":"10.1021\/acsami.8b08125","volume":"10","author":"J Zhai","year":"2018","unstructured":"Zhai J, Luwor RB, Ahmed N, Escalona RM, Tan FH, Fong C, Ratcliffe J, Scoble JA, Drummond CJ, Tran N (2018) Paclitaxel-loaded self-assembled lipid nanoparticles as targeted drug delivery systems for the treatment of aggressive ovarian cancer. ACS Appl Mater Interfaces 10(30):25174\u201325185. https:\/\/doi.org\/10.1021\/acsami.8b08125","journal-title":"ACS Appl Mater Interfaces"},{"key":"2346_CR276","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00990-3","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X (2020) Targeting the Wnt\/\u03b2-catenin signalling pathway in cancer. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-020-00990-3","journal-title":"J Hematol Oncol"},{"issue":"11","key":"2346_CR265","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1021\/acs.molpharmaceut.7b00469","volume":"14","author":"C Zhang","year":"2017","unstructured":"Zhang C, Wang C, Li W, Wu R, Guo Y, Cheng D, Yang Y, Androulakis IP, Kong AT (2017) Pharmacokinetics and pharmacodynamics of the triterpenoid ursolic acid in regulating the antioxidant, anti-inflammatory, and epigenetic gene responses in rat leukocytes. Mol Pharm 14(11):3709\u20133717. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00469","journal-title":"Mol Pharm"},{"key":"2346_CR273","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13116-2","author":"S Zhang","year":"2019","unstructured":"Zhang S, Dolgalev I, Zhang T, Ran H, Levine DA, Neel BG (2019) Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-13116-2","journal-title":"Nat Commun"},{"issue":"4","key":"2346_CR271","doi-asserted-by":"publisher","first-page":"259","DOI":"10.37349\/etat.2020.00017","volume":"1","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhang X, Liu X, Khan S, Zhou D, Zheng G (2020) PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors. Explor Target Anti-Tumor Therapy 1(4):259\u2013272. https:\/\/doi.org\/10.37349\/etat.2020.00017","journal-title":"Explor Target Anti-Tumor Therapy"},{"issue":"5","key":"2346_CR269","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/febs.16350","volume":"290","author":"L Zhang","year":"2022","unstructured":"Zhang L, Pitcher LE, Prahalad V, Niedernhofer LJ, Robbins PD (2022a) Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. FEBS J 290(5):1362\u20131383. https:\/\/doi.org\/10.1111\/febs.16350","journal-title":"FEBS J"},{"key":"2346_CR270","doi-asserted-by":"publisher","DOI":"10.1172\/jci158450","author":"L Zhang","year":"2022","unstructured":"Zhang L, Pitcher LE, Yousefzadeh MJ, Niedernhofer LJ, Robbins PD, Zhu Y (2022b) Cellular senescence: a key therapeutic target in aging and diseases. J Clin Invest. https:\/\/doi.org\/10.1172\/jci158450","journal-title":"J Clin Invest"},{"key":"2346_CR267","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1160985","author":"J Zhang","year":"2023","unstructured":"Zhang J, Ding H, Zhang F, Xu Y, Liang W, Huang L (2023a) New trends in diagnosing and treating ovarian cancer using nanotechnology. Front Bioeng Biotechnol. https:\/\/doi.org\/10.3389\/fbioe.2023.1160985","journal-title":"Front Bioeng Biotechnol"},{"issue":"10","key":"2346_CR268","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.7150\/ijbs.82401","volume":"19","author":"J Zhang","year":"2023","unstructured":"Zhang J, Xu H, Zhu J, Dou Y, Xian Y, Lin Z (2023b) Natural Nrf2 inhibitors: a review of their potential for cancer treatment. Int J Biol Sci 19(10):3029\u20133041. https:\/\/doi.org\/10.7150\/ijbs.82401","journal-title":"Int J Biol Sci"},{"key":"2346_CR272","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2024.12438","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Lou Y, Fang H, Sun S, Jin R, Ji Y, Chen Z (2024) Cancer\u2013associated fibroblasts under therapy\u2013induced senescence in the tumor microenvironment (Review). Exp Therapeutic Med. https:\/\/doi.org\/10.3892\/etm.2024.12438","journal-title":"Experimental Therapeutic Med"},{"key":"2346_CR266","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412950","author":"H Zhang","year":"2025","unstructured":"Zhang H, Xu Q, Jiang Z, Sun R, Wang Q, Liu S, Luan X, Campisi J, Kirkland JL, Zhang W, Sun Y (2025a) Targeting senescence with apigenin improves chemotherapeutic efficacy and ameliorates age-related conditions in mice. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202412950","journal-title":"Adv Sci"},{"key":"2346_CR275","doi-asserted-by":"publisher","first-page":"102380","DOI":"10.1016\/j.tranon.2025.102380","volume":"56","author":"X Zhang","year":"2025","unstructured":"Zhang X, Xiong B, Cheng Y, Huang J, Xue J, Li X, Lu W, Zhu J, Wang L, Yang W, Cheng Z (2025b) Berberine inhibits metastasis of ovarian cancer by blocking lipid metabolism, alleviating aging of adipose tissue and increasing tumor infiltrating immune cells. Trans Oncol 56:102380\u2013102380. https:\/\/doi.org\/10.1016\/j.tranon.2025.102380","journal-title":"Translational Oncol"},{"key":"2346_CR274","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-026-00355-z","author":"W Zhang","year":"2026","unstructured":"Zhang W, Song S, Zhang Y, Pan Y, Hu D, Wang Y (2026) Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming. Npj Aging. https:\/\/doi.org\/10.1038\/s41514-026-00355-z","journal-title":"Npj Aging"},{"issue":"8","key":"2346_CR280","doi-asserted-by":"publisher","first-page":"623","DOI":"10.18632\/aging.100593","volume":"5","author":"S Zhao","year":"2013","unstructured":"Zhao S, Halicka HD, Li J, Dar\u017cynkiewicz Z (2013) Berberine suppresses gero-conversion from cell cycle arrest to senescence. Aging 5(8):623\u2013636. https:\/\/doi.org\/10.18632\/aging.100593","journal-title":"Aging"},{"key":"2346_CR278","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00658-5","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y (2021) Inflammation and tumor progression: signalling pathways and targeted intervention. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-021-00658-5","journal-title":"Signal Transduct Target Therapy"},{"key":"2346_CR277","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01426-4","author":"B Zhao","year":"2023","unstructured":"Zhao B, Wu B, Feng N, Zhang X, Zhang X, Wei Y, Zhang W (2023) Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-023-01426-4","journal-title":"J Hematol Oncol"},{"key":"2346_CR279","doi-asserted-by":"publisher","first-page":"1727142","DOI":"10.3389\/fimmu.2026.1727142","volume":"17","author":"Q Zhao","year":"2026","unstructured":"Zhao Q, Yu Y, Pu C, Zheng S, Chen L, Zeng F, Liu L, Li D (2026) Research progress on the spatiotemporal dynamics of therapy-induced senescence in remodelling the tumor microenvironment. Front Immunol 17:1727142\u20131727142. https:\/\/doi.org\/10.3389\/fimmu.2026.1727142","journal-title":"Front Immunol"},{"key":"2346_CR281","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2024.0206","author":"L Zheng","year":"2024","unstructured":"Zheng L, He S, Wang H, Li J, Liu Y, Liu S (2024) Targeting cellular senescence in aging and age-related diseases: challenges, considerations, and the emerging role of senolytic and senomorphic therapies. Aging Dis. https:\/\/doi.org\/10.14336\/ad.2024.0206","journal-title":"Aging Disease"},{"issue":"23","key":"2346_CR286","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1039\/c6cs00271d","volume":"45","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Song J, Nie L, Chen X (2016) Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem Soc Rev 45(23):6597\u20136626. https:\/\/doi.org\/10.1039\/c6cs00271d","journal-title":"Chem Soc Rev"},{"key":"2346_CR282","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01271-8","author":"C Zhou","year":"2023","unstructured":"Zhou C, Huang Y, Nie S, Zhou S, Gao X, Chen G (2023) Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent. Eur J Med Res0. https:\/\/doi.org\/10.1186\/s40001-023-01271-8","journal-title":"Eur J Med Res0"},{"key":"2346_CR283","doi-asserted-by":"publisher","first-page":"119126","DOI":"10.1016\/j.jep.2024.119126","volume":"338","author":"J Zhou","year":"2024","unstructured":"Zhou J, Guo Z, Peng X, Wu B, Meng Q, Lu X, Feng L, Guo T (2024a) Chrysotoxine regulates ferroptosis and the PI3K\/AKT\/mTOR pathway to prevent cervical cancer. J Ethnopharmacol 338:119126\u2013119126. https:\/\/doi.org\/10.1016\/j.jep.2024.119126","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"2346_CR284","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/s41598-024-52413-9","volume":"14","author":"J Zhou","year":"2024","unstructured":"Zhou J, Li H, Wu B, Zhu L, Huang Q, Guo Z, He Q, Wang L, Peng X, Guo T (2024b) Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer. Sci Rep 14(1):1860\u20131860. https:\/\/doi.org\/10.1038\/s41598-024-52413-9","journal-title":"Sci Rep"},{"key":"2346_CR285","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01823-2","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y, Tian X, Guan X, Cen X, Zhao Y (2024c) Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-024-01823-2","journal-title":"Signal Transduct Target Therapy"},{"issue":"3","key":"2346_CR290","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/acel.12445","volume":"15","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H, Dai H, Ling Y, Stout MB, Pirtskhalava T, Giorgadze N, Johnson KO, Giles CB, Wren JD, Niedernhofer LJ, Robbins PD, Kirkland JL (2015) Identification of a novel senolytic agent, navitoclax, targeting the Bcl\u20102 family of anti\u2010apoptotic factors. Aging Cell 15(3):428\u2013435. https:\/\/doi.org\/10.1111\/acel.12445","journal-title":"Aging Cell"},{"issue":"3","key":"2346_CR289","doi-asserted-by":"publisher","first-page":"955","DOI":"10.18632\/aging.101202","volume":"9","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Doornebal EJ, Pirtskhalava T, Giorgadze N, Wentworth M, Fuhrmann-Stroissnigg H, Niedernhofer LJ, Robbins PD, Tchkonia T, Kirkland JL (2017) New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging 9(3):955\u2013963. https:\/\/doi.org\/10.18632\/aging.101202","journal-title":"Aging"},{"key":"2346_CR287","doi-asserted-by":"publisher","DOI":"10.1177\/2040622320964125","author":"M Zhu","year":"2020","unstructured":"Zhu M, Meng P, Ling X, Zhou L (2020) Advancements in therapeutic drugs targeting of senescence. Ther Adv Chronic Dis. https:\/\/doi.org\/10.1177\/2040622320964125","journal-title":"Therapeutic Adv Chronic Disease"},{"key":"2346_CR288","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00646-9","author":"X Zhu","year":"2021","unstructured":"Zhu X, Chen Z, Shen W, Huang G, Sedivy JM, Wang H, Ju Z (2021) Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-021-00646-9","journal-title":"Signal Transduct Target Therapy"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02346-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:43:47Z","timestamp":1787924627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02346-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":290,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2346"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02346-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}